data_2gvb_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2gvb _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.527 ' SD ' ' CG2' ' A' ' 62' ' ' THR . 26.5 ttm . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 121.37 0.605 . . . . 6.9199999999999999 109.419 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.557 ' CG2' HG22 ' A' ' 63' ' ' VAL . 2.4 mt -76.91 80.9 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 N-CA-C 108.063 -1.088 . . . . 2.5800000000000001 108.063 179.534 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.439 ' O ' ' CG1' ' A' ' 35' ' ' VAL . 36.6 mttt -64.05 177.23 0.82 Allowed 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 121.961 0.886 . . . . 2.8300000000000001 111.705 -178.033 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.588 ' O ' ' N ' ' A' ' 61' ' ' TYR . 2.0 p 172.24 149.7 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 N-CA-C 108.84 -0.8 . . . . 3.9700000000000002 108.84 179.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.557 ' N ' HG21 ' A' ' 4' ' ' VAL . 43.7 mt-10 -123.62 113.79 19.14 Favored 'General case' 0 C--N 1.293 -1.862 0 O-C-N 121.361 -0.837 . . . . 3.8399999999999999 109.808 -179.718 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.593 HD11 ' CE1' ' A' ' 61' ' ' TYR . 0.2 OUTLIER -73.63 101.3 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 N-CA-C 107.794 -1.187 . . . . 1.47 107.794 179.001 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.646 ' HD3' ' CD2' ' A' ' 34' ' ' TYR . 0.0 OUTLIER -44.15 170.01 0.05 OUTLIER Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.403 -0.811 . . . . 2.4100000000000001 110.013 -179.031 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.461 ' HD2' ' HB3' ' A' ' 7' ' ' LYS . 33.1 Cg_endo -74.69 -25.0 12.97 Favored 'Trans proline' 0 C--N 1.31 -1.486 0 C-N-CA 122.475 2.117 . . . . 2.71 109.746 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -90.01 -0.2 57.46 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 108.937 -0.764 . . . . 3.4500000000000002 108.937 178.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.509 ' NE2' HD12 ' A' ' 44' ' ' LEU . 6.2 mm-40 -118.42 38.23 3.79 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.278 -0.889 . . . . 4.6299999999999999 109.225 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -103.26 10.32 37.68 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.137 -0.977 . . . . 1.8100000000000001 110.348 -179.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.418 ' HA ' ' CB ' ' A' ' 55' ' ' ALA . 34.5 mt-30 -136.63 135.8 38.61 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.047 -1.033 . . . . 5.6500000000000004 110.05 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.628 ' CD1' ' HB3' ' A' ' 29' ' ' ASN . 28.5 p90 -86.13 170.9 11.77 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.387 -0.821 . . . . 2.9500000000000002 109.497 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 96.6 m -136.75 151.16 48.89 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.395 -0.816 . . . . 4.4400000000000004 108.952 179.162 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.03 112.63 22.05 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.251 -0.906 . . . . 2.8900000000000001 109.419 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -129.45 147.71 51.29 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.302 -0.874 . . . . 9.2200000000000006 109.397 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -54.38 106.98 0.23 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.237 -0.915 . . . . 3.5299999999999998 109.427 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.574 ' HA3' ' CE1' ' A' ' 26' ' ' TYR . . . -104.9 165.31 14.45 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 109.425 -1.47 . . . . 6.1399999999999997 109.425 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.422 ' C ' ' CE2' ' A' ' 26' ' ' TYR . 0.9 OUTLIER -135.99 115.07 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.166 -1.197 . . . . 9.2699999999999996 108.937 179.435 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.473 ' N ' ' CE2' ' A' ' 26' ' ' TYR . 0.5 OUTLIER -46.91 -78.81 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.437 -0.79 . . . . 11.289999999999999 109.552 -179.258 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.486 ' O ' ' CB ' ' A' ' 22' ' ' GLN . 56.8 mtp180 -148.62 53.25 0.99 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.28 -0.887 . . . . 9.5099999999999998 109.555 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.486 ' CB ' ' O ' ' A' ' 21' ' ' ARG . 5.2 mt-30 73.31 20.96 3.14 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.254 -0.904 . . . . 13.35 109.356 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.445 ' C ' ' CG ' ' A' ' 24' ' ' LYS . . . -106.21 -51.39 0.83 Allowed Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.499 -1.441 . . . . 7.9000000000000004 109.499 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.445 ' CG ' ' C ' ' A' ' 23' ' ' GLY . 1.1 mttt -154.85 149.85 20.5 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.279 -1.13 . . . . 5.46 109.455 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -78.37 115.85 3.76 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.689 2.259 . . . . 5.3799999999999999 110.231 179.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.605 ' O ' ' CD1' ' A' ' 26' ' ' TYR . 6.3 p90 -111.19 141.08 45.18 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.167 -0.958 . . . . 7.2800000000000002 109.644 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -97.99 79.03 2.58 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.175 -0.953 . . . . 4.0599999999999996 108.779 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.58 ' HB2' ' CD1' ' A' ' 26' ' ' TYR . 0.2 OUTLIER -92.41 170.68 9.58 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.229 -0.919 . . . . 7.71 110.292 -179.187 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.628 ' HB3' ' CD1' ' A' ' 13' ' ' PHE . 0.0 OUTLIER -92.97 121.95 34.84 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 108.637 -0.875 . . . . 4.9000000000000004 108.637 179.505 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.47 ' O ' ' HA ' ' A' ' 13' ' ' PHE . 2.8 mt-10 -109.93 156.07 20.91 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.061 -1.024 . . . . 3.29 109.763 -179.461 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.538 ' HB3' ' CG2' ' A' ' 47' ' ' ILE . 0.0 OUTLIER -137.67 -169.26 2.5 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.227 -0.92 . . . . 3.2799999999999998 109.771 179.972 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.491 ' HB3' ' CD1' ' A' ' 44' ' ' LEU . 1.2 mt -134.77 173.85 11.23 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.449 -0.782 . . . . 2.5899999999999999 109.34 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.52 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -168.38 165.87 12.58 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 108.3 -1.0 . . . . 1.8300000000000001 108.3 -179.856 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.653 ' CD1' ' HB2' ' A' ' 42' ' ' PRO . 18.1 m-85 -119.55 96.7 5.31 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.036 -1.04 . . . . 3.3399999999999999 109.472 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.526 ' O ' ' CG2' ' A' ' 43' ' ' VAL . 3.0 t -95.43 113.6 30.19 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 O-C-N 121.219 -0.926 . . . . 1.53 110.597 -179.446 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.44 ' O ' ' N ' ' A' ' 39' ' ' ASN . 1.4 m-20 -62.77 -35.47 79.92 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 107.023 -1.473 . . . . 3.9900000000000002 107.023 178.139 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.555 ' CG ' ' O ' ' A' ' 37' ' ' LEU . 3.3 tt 48.98 21.4 0.46 Allowed 'General case' 0 N--CA 1.491 1.593 0 CA-C-O 121.62 0.724 . . . . 2.3999999999999999 110.071 178.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 88.46 14.14 62.24 Favored Glycine 0 N--CA 1.48 1.626 0 N-CA-C 109.075 -1.61 . . . . 2.7000000000000002 109.075 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.526 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 42.8 m-20 -94.7 12.95 25.99 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.371 -1.076 . . . . 3.5099999999999998 109.777 -179.683 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.526 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 19.5 mt-10 70.68 -52.31 0.67 Allowed 'General case' 0 N--CA 1.498 1.97 0 CA-C-O 121.645 0.736 . . . . 4.0999999999999996 110.363 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . 0.472 ' HB3' ' HD2' ' A' ' 42' ' ' PRO . 18.1 m80 -97.71 161.52 25.5 Favored Pre-proline 0 C--N 1.291 -1.971 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.653 ' HB2' ' CD1' ' A' ' 34' ' ' TYR . 37.0 Cg_endo -77.72 138.06 16.65 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 C-N-CA 122.118 1.879 . . . . 3.4500000000000002 110.257 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.539 ' CG2' ' O ' ' A' ' 43' ' ' VAL . 3.9 m -110.76 115.14 49.05 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 C-N-CA 119.425 -0.91 . . . . 3.5800000000000001 109.207 179.381 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.575 ' HB2' ' CE1' ' A' ' 34' ' ' TYR . 60.9 tp -67.98 101.31 1.1 Allowed 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.213 -0.929 . . . . 2.6499999999999999 109.01 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.526 HG22 ' CG1' ' B' ' 70' ' ' VAL . 0.3 OUTLIER -110.44 157.94 10.95 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 N-CA-C 109.099 -0.704 . . . . 2.6600000000000001 109.099 -179.552 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.465 ' HB2' ' O ' ' B' ' 74' ' ' GLY . 9.3 mtpt -81.49 172.62 13.29 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.072 -1.017 . . . . 3.8900000000000001 110.187 -179.255 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.639 HG12 ' CE1' ' A' ' 56' ' ' TYR . 0.5 OUTLIER -159.91 154.19 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 N-CA-C 108.622 -0.881 . . . . 4.0700000000000003 108.622 179.87 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.45 HG23 ' CZ ' ' A' ' 80' ' ' ARG . 0.2 OUTLIER -94.86 149.02 21.69 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.978 -1.076 . . . . 3.4399999999999999 109.529 -179.993 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.604 ' HG ' ' CD2' ' A' ' 13' ' ' PHE . 0.2 OUTLIER -119.11 113.13 20.43 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.802 -0.814 . . . . 4.5700000000000003 108.802 179.873 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.432 ' O ' ' ND2' ' A' ' 29' ' ' ASN . 0.1 OUTLIER -53.4 149.79 7.22 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.242 -0.911 . . . . 4.7699999999999996 109.864 -179.43 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -63.09 117.45 6.51 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.309 -0.87 . . . . 6.4900000000000002 109.348 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 96.06 -18.36 57.58 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.456 -1.457 . . . . 4.0999999999999996 109.456 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.46 ' O ' HD13 ' A' ' 49' ' ' LEU . 0.4 OUTLIER -75.13 144.32 78.72 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.239 -1.153 . . . . 3.0600000000000001 109.28 179.92 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.442 ' O ' ' C ' ' A' ' 55' ' ' ALA . 35.4 Cg_endo -78.25 123.64 6.2 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.563 2.175 . . . . 3.1600000000000001 110.53 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.485 ' HA ' ' CD2' ' A' ' 49' ' ' LEU . . . -41.15 146.78 0.16 Allowed 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.411 -0.806 . . . . 1.73 110.092 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.639 ' CE1' HG12 ' A' ' 47' ' ' ILE . 87.1 m-85 -47.65 99.34 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.358 -0.839 . . . . 2.4399999999999999 108.888 179.649 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.442 ' CB ' ' HD2' ' A' ' 58' ' ' PRO . . . -47.37 171.79 0.07 OUTLIER Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.253 -0.904 . . . . 1.1599999999999999 109.557 -179.764 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.472 ' HA ' HG23 ' A' ' 6' ' ' ILE . 35.2 Cg_endo -78.03 112.24 3.22 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 122.656 2.238 . . . . 1.99 110.277 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 175.62 -178.14 47.25 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.645 -1.382 . . . . 0.91000000000000003 109.645 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.573 ' O ' ' CD1' ' A' ' 61' ' ' TYR . 0.1 OUTLIER -73.02 162.2 29.77 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.245 -1.15 . . . . 2.7799999999999998 108.191 179.307 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.593 ' CE1' HD11 ' A' ' 6' ' ' ILE . 23.2 m-85 -147.49 164.56 33.0 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-O 122.45 1.119 . . . . 2.48 111.437 -179.184 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.527 ' CG2' ' SD ' ' A' ' 1' ' ' MET . 21.2 p -147.64 119.37 8.06 Favored 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 106.299 -1.741 . . . . 3.4500000000000002 106.299 178.26 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.591 ' CG1' ' HB2' ' A' ' 81' ' ' LEU . 10.0 t -52.55 169.18 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.286 -2.175 0 C-N-CA 118.495 -1.282 . . . . 2.54 108.708 -178.498 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.49 ' CB ' ' O ' ' A' ' 82' ' ' ARG . 2.1 t-80 -132.32 127.36 35.4 Favored 'General case' 0 C--N 1.293 -1.876 0 O-C-N 121.443 -0.785 . . . . 3.8100000000000001 109.127 -179.213 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.638 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 0.6 OUTLIER -72.73 1.82 7.74 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.385 -0.822 . . . . 4.2000000000000002 109.976 -179.961 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -57.2 -19.67 22.29 Favored 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 107.287 -1.375 . . . . 1.79 107.287 178.553 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.528 ' CB ' ' O ' ' A' ' 80' ' ' ARG . 48.5 m -95.67 -10.38 29.51 Favored 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.84 -0.537 . . . . 3.21 109.798 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.638 ' CD2' ' HB2' ' A' ' 65' ' ' LEU . 2.8 m-30 -77.88 155.89 30.68 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.136 -0.977 . . . . 2.73 109.772 -178.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.535 ' CA ' HD12 ' B' ' 37' ' ' LEU . 3.7 mtmt -150.45 165.01 34.47 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.369 -0.832 . . . . 2.6099999999999999 109.334 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.527 ' CG1' HG22 ' B' ' 45' ' ' VAL . 1.7 t -97.91 117.59 42.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.312 -0.868 . . . . 2.02 109.133 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -79.16 172.2 55.15 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.585 -1.406 . . . . 2.5299999999999998 109.585 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -77.04 1.02 19.15 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.096 -1.238 . . . . 6.7300000000000004 109.893 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -89.49 1.75 55.48 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 121.544 -0.723 . . . . 2.8999999999999999 109.347 179.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.469 ' O ' ' HB2' ' B' ' 46' ' ' LYS . . . 70.31 50.35 27.58 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.508 -1.437 . . . . 2.6200000000000001 109.508 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.509 ' N ' HG23 ' B' ' 45' ' ' VAL . 40.5 m -161.52 127.81 3.81 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.113 -1.228 . . . . 2.7799999999999998 109.547 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.531 ' O ' ' CG ' ' A' ' 77' ' ' MET . 0.3 OUTLIER -53.48 154.32 3.58 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.232 -0.918 . . . . 1.3400000000000001 109.323 179.937 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' MET . . . . . 0.531 ' CG ' ' O ' ' A' ' 76' ' ' LEU . 22.4 mtp -160.29 117.49 2.49 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.228 -0.92 . . . . 3.7599999999999998 109.474 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.618 HG12 ' CE1' ' A' ' 68' ' ' PHE . 4.9 mt -59.01 134.35 24.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.29 -0.881 . . . . 1.52 109.565 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.43 ' CG ' ' HE2' ' A' ' 69' ' ' LYS . 26.5 t70 -103.22 -21.13 13.9 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.285 -1.005 . . . . 2.4100000000000001 108.285 178.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.528 ' O ' ' CB ' ' A' ' 67' ' ' SER . 0.0 OUTLIER 174.47 68.95 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 107.304 -1.369 . . . . 1.75 107.304 179.357 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.591 ' HB2' ' CG1' ' A' ' 63' ' ' VAL . 0.9 OUTLIER -31.48 121.35 0.25 Allowed 'General case' 0 C--N 1.297 -1.693 0 CA-C-N 115.285 -0.87 . . . . 3.6200000000000001 111.797 -178.151 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.49 ' O ' ' CB ' ' A' ' 64' ' ' HIS . 0.1 OUTLIER -90.7 104.24 16.85 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.004 -1.11 . . . . 8.0700000000000003 108.004 178.678 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.611 ' HB3' ' CE2' ' A' ' 56' ' ' TYR . 0.5 OUTLIER -73.47 148.85 42.8 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.271 -0.893 . . . . 2.6899999999999999 111.099 -178.474 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.522 ' CG2' ' O ' ' A' ' 62' ' ' THR . 25.0 m -148.79 156.12 41.2 Favored Pre-proline 0 C--N 1.302 -1.49 0 N-CA-C 107.872 -1.159 . . . . 2.8599999999999999 107.872 179.498 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.512 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 24.1 Cg_endo -62.42 147.84 94.25 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 C-N-CA 122.022 1.814 . . . . 2.8599999999999999 110.604 179.035 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.465 ' CB ' HG21 ' A' ' 62' ' ' THR . . . -87.13 130.39 34.54 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.179 -0.951 . . . . 3.6400000000000001 109.421 -178.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.509 0 CA-C-O 118.0 -1.0 . . . . 8.9499999999999993 109.531 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.526 ' SD ' ' CG2' ' B' ' 62' ' ' THR . 26.4 ttm . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 121.397 0.617 . . . . 6.9199999999999999 109.38 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 2' ' ' ILE . . . . . 0.553 ' CG2' HG22 ' B' ' 63' ' ' VAL . 2.4 mt -76.98 80.83 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 N-CA-C 108.025 -1.102 . . . . 2.5699999999999998 108.025 179.582 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . 0.453 ' O ' ' CG1' ' B' ' 35' ' ' VAL . 36.7 mttt -64.02 177.17 0.83 Allowed 'General case' 0 N--CA 1.493 1.698 0 CA-C-O 121.964 0.888 . . . . 2.8300000000000001 111.674 -178.061 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 4' ' ' VAL . . . . . 0.593 ' O ' ' N ' ' B' ' 61' ' ' TYR . 2.0 p 172.27 149.74 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 N-CA-C 108.807 -0.812 . . . . 3.9700000000000002 108.807 179.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 5' ' ' GLU . . . . . 0.569 ' N ' HG21 ' B' ' 4' ' ' VAL . 44.2 mt-10 -123.67 113.8 19.12 Favored 'General case' 0 C--N 1.292 -1.903 0 O-C-N 121.336 -0.853 . . . . 3.8399999999999999 109.789 -179.736 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . 0.608 HD11 ' CE1' ' B' ' 61' ' ' TYR . 0.2 OUTLIER -73.64 101.32 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 N-CA-C 107.757 -1.201 . . . . 1.47 107.757 179.004 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 7' ' ' LYS . . . . . 0.642 ' HD3' ' CD2' ' B' ' 34' ' ' TYR . 0.0 OUTLIER -44.14 170.03 0.05 OUTLIER Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.386 -0.821 . . . . 2.4100000000000001 110.013 -179.06 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 8' ' ' PRO . . . . . 0.471 ' HD2' ' HB3' ' B' ' 7' ' ' LYS . 33.2 Cg_endo -74.66 -25.06 12.97 Favored 'Trans proline' 0 C--N 1.311 -1.443 0 C-N-CA 122.415 2.077 . . . . 2.71 109.813 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -89.91 -0.27 57.47 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 108.93 -0.767 . . . . 3.4500000000000002 108.93 178.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 10' ' ' GLN . . . . . 0.521 ' NE2' HD12 ' B' ' 44' ' ' LEU . 6.2 mm-40 -118.38 38.25 3.78 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.325 -0.859 . . . . 4.6299999999999999 109.25 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -103.3 10.35 37.6 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.124 -0.985 . . . . 1.8100000000000001 110.333 -179.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 12' ' ' GLN . . . . . 0.413 ' HA ' ' CB ' ' B' ' 55' ' ' ALA . 34.5 mt-30 -136.67 135.71 38.46 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.044 -1.035 . . . . 5.6600000000000001 110.036 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 13' ' ' PHE . . . . . 0.615 ' CD1' ' HB3' ' B' ' 29' ' ' ASN . 28.6 p90 -86.05 170.83 11.89 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.409 -0.807 . . . . 2.9500000000000002 109.519 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 96.6 m -136.73 151.15 48.9 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.378 -0.826 . . . . 4.4400000000000004 108.972 179.16 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.06 112.66 22.09 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.239 -0.913 . . . . 2.8900000000000001 109.41 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -129.47 147.71 51.31 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.328 -0.858 . . . . 9.2200000000000006 109.376 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -54.43 107.02 0.24 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.277 -0.89 . . . . 3.5299999999999998 109.429 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 18' ' ' GLY . . . . . 0.584 ' HA3' ' CE1' ' B' ' 26' ' ' TYR . . . -104.89 165.29 14.46 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.418 -1.473 . . . . 6.1399999999999997 109.418 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 19' ' ' VAL . . . . . 0.423 ' C ' ' CE2' ' B' ' 26' ' ' TYR . 0.9 OUTLIER -135.98 115.1 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.188 -1.184 . . . . 9.2699999999999996 108.91 179.429 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 20' ' ' SER . . . . . 0.471 ' N ' ' CE2' ' B' ' 26' ' ' TYR . 0.5 OUTLIER -46.91 -78.85 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.394 -0.816 . . . . 11.300000000000001 109.552 -179.313 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 21' ' ' ARG . . . . . 0.465 ' O ' ' CB ' ' B' ' 22' ' ' GLN . 56.9 mtp180 -148.56 53.17 1.0 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.272 -0.892 . . . . 9.5199999999999996 109.6 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 22' ' ' GLN . . . . . 0.465 ' CB ' ' O ' ' B' ' 21' ' ' ARG . 5.2 mt-30 73.38 20.98 3.09 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.176 -0.952 . . . . 13.35 109.323 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 23' ' ' GLY . . . . . 0.445 ' C ' ' CG ' ' B' ' 24' ' ' LYS . . . -106.22 -51.37 0.83 Allowed Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.534 -1.426 . . . . 7.9000000000000004 109.534 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 24' ' ' LYS . . . . . 0.445 ' CG ' ' C ' ' B' ' 23' ' ' GLY . 1.1 mttt -154.86 149.78 20.38 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.203 -1.175 . . . . 5.46 109.541 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -78.28 115.77 3.77 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 122.727 2.284 . . . . 5.3799999999999999 110.316 179.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 26' ' ' TYR . . . . . 0.603 ' O ' ' CD1' ' B' ' 26' ' ' TYR . 6.3 p90 -111.08 141.07 45.06 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.127 -0.983 . . . . 7.2800000000000002 109.718 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 27' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -98.03 78.97 2.56 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.148 -0.97 . . . . 4.0599999999999996 108.727 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . 0.582 ' HB2' ' CD1' ' B' ' 26' ' ' TYR . 0.2 OUTLIER -92.39 170.64 9.62 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.195 -0.94 . . . . 7.71 110.298 -179.197 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 29' ' ' ASN . . . . . 0.615 ' HB3' ' CD1' ' B' ' 13' ' ' PHE . 0.0 OUTLIER -92.92 121.92 34.76 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.623 -0.88 . . . . 4.9000000000000004 108.623 179.559 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 30' ' ' GLU . . . . . 0.456 ' O ' ' HA ' ' B' ' 13' ' ' PHE . 2.8 mt-10 -109.94 156.05 20.95 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.097 -1.002 . . . . 3.29 109.77 -179.45 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 31' ' ' GLN . . . . . 0.548 ' HB3' ' CG2' ' B' ' 47' ' ' ILE . 0.0 OUTLIER -137.63 -169.26 2.49 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.25 -0.906 . . . . 3.2799999999999998 109.829 179.948 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . 0.489 ' HB3' ' CD1' ' B' ' 44' ' ' LEU . 1.2 mt -134.74 173.86 11.21 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.429 -0.794 . . . . 2.5899999999999999 109.34 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 33' ' ' CYS . . . . . 0.507 ' O ' ' HA ' ' B' ' 44' ' ' LEU . 0.0 OUTLIER -168.36 165.94 12.6 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.058 -1.026 . . . . 1.8300000000000001 108.274 -179.812 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 34' ' ' TYR . . . . . 0.657 ' CD1' ' HB2' ' B' ' 42' ' ' PRO . 17.8 m-85 -119.66 96.66 5.28 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.053 -1.029 . . . . 3.3399999999999999 109.438 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 35' ' ' VAL . . . . . 0.528 ' O ' ' CG2' ' B' ' 43' ' ' VAL . 2.9 t -95.37 113.65 30.24 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 O-C-N 121.196 -0.94 . . . . 1.52 110.658 -179.469 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 36' ' ' ASP . . . . . 0.439 ' O ' ' N ' ' B' ' 39' ' ' ASN . 1.4 m-20 -62.82 -35.53 80.2 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 106.989 -1.486 . . . . 3.9900000000000002 106.989 178.174 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 37' ' ' LEU . . . . . 0.55 ' CG ' ' O ' ' B' ' 37' ' ' LEU . 3.3 tt 49.09 21.35 0.48 Allowed 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 121.614 0.721 . . . . 2.3999999999999999 110.039 178.698 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 88.35 14.33 62.16 Favored Glycine 0 N--CA 1.482 1.701 0 N-CA-C 109.094 -1.602 . . . . 2.7000000000000002 109.094 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 39' ' ' ASN . . . . . 0.529 ' O ' ' HB2' ' B' ' 40' ' ' GLU . 42.2 m-20 -94.74 12.89 26.3 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.333 -1.098 . . . . 3.5099999999999998 109.82 -179.756 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 40' ' ' GLU . . . . . 0.529 ' HB2' ' O ' ' B' ' 39' ' ' ASN . 19.5 mt-10 70.61 -52.36 0.66 Allowed 'General case' 0 N--CA 1.499 1.995 0 CA-C-O 121.663 0.744 . . . . 4.1100000000000003 110.356 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 41' ' ' HIS . . . . . 0.474 ' HB3' ' HD2' ' B' ' 42' ' ' PRO . 18.3 m80 -97.59 161.58 25.38 Favored Pre-proline 0 C--N 1.291 -1.974 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 42' ' ' PRO . . . . . 0.657 ' HB2' ' CD1' ' B' ' 34' ' ' TYR . 37.0 Cg_endo -77.83 137.99 16.38 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 122.068 1.845 . . . . 3.4399999999999999 110.287 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 43' ' ' VAL . . . . . 0.53 ' CG2' ' O ' ' B' ' 43' ' ' VAL . 3.9 m -110.66 115.17 49.11 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 O-C-N 121.221 -0.924 . . . . 3.5800000000000001 109.207 179.421 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . 0.581 ' HB2' ' CE1' ' B' ' 34' ' ' TYR . 60.7 tp -68.03 101.26 1.1 Allowed 'General case' 0 C--N 1.302 -1.496 0 C-N-CA 119.331 -0.948 . . . . 2.6499999999999999 109.056 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 45' ' ' VAL . . . . . 0.527 HG22 ' CG1' ' A' ' 70' ' ' VAL . 0.3 OUTLIER -110.37 157.94 10.85 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 N-CA-C 109.121 -0.696 . . . . 2.6600000000000001 109.121 -179.48 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 46' ' ' LYS . . . . . 0.469 ' HB2' ' O ' ' A' ' 74' ' ' GLY . 9.3 mtpt -81.52 172.63 13.25 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.087 -1.008 . . . . 3.8900000000000001 110.177 -179.252 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 47' ' ' ILE . . . . . 0.649 HG12 ' CE1' ' B' ' 56' ' ' TYR . 0.5 OUTLIER -159.83 154.29 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 N-CA-C 108.728 -0.842 . . . . 4.0700000000000003 108.728 179.814 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 48' ' ' THR . . . . . 0.449 HG23 ' CZ ' ' B' ' 80' ' ' ARG . 0.2 OUTLIER -95.0 149.02 21.7 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.03 -1.044 . . . . 3.4399999999999999 109.579 -179.998 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 49' ' ' LEU . . . . . 0.6 ' HG ' ' CD2' ' B' ' 13' ' ' PHE . 0.2 OUTLIER -119.1 113.13 20.44 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.802 -0.814 . . . . 4.5700000000000003 108.802 179.932 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 50' ' ' ASP . . . . . 0.423 ' O ' ' ND2' ' B' ' 29' ' ' ASN . 0.1 OUTLIER -53.36 149.8 7.1 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.242 -0.911 . . . . 4.7699999999999996 109.941 -179.455 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -63.12 117.44 6.51 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.355 -0.841 . . . . 6.4900000000000002 109.404 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . 96.06 -18.32 57.66 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.456 -1.457 . . . . 4.1100000000000003 109.456 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 53' ' ' GLN . . . . . 0.463 ' O ' HD13 ' B' ' 49' ' ' LEU . 0.4 OUTLIER -75.22 144.3 78.35 Favored Pre-proline 0 N--CA 1.488 1.44 0 O-C-N 121.176 -1.19 . . . . 3.0600000000000001 109.318 179.961 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 54' ' ' PRO . . . . . 0.424 ' O ' ' C ' ' B' ' 55' ' ' ALA . 35.5 Cg_endo -78.28 123.65 6.18 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.578 2.185 . . . . 3.1600000000000001 110.566 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 55' ' ' ALA . . . . . 0.48 ' HA ' ' CD2' ' B' ' 49' ' ' LEU . . . -41.07 146.69 0.16 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.338 -0.851 . . . . 1.73 110.152 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 56' ' ' TYR . . . . . 0.649 ' CE1' HG12 ' B' ' 47' ' ' ILE . 87.7 m-85 -47.58 98.08 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.376 -0.827 . . . . 2.4500000000000002 109.004 179.725 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 57' ' ' ALA . . . . . 0.457 ' O ' ' O ' ' B' ' 56' ' ' TYR . . . -46.2 171.75 0.06 OUTLIER Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.187 -0.945 . . . . 1.1599999999999999 109.698 -179.513 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 58' ' ' PRO . . . . . 0.474 ' HA ' HG23 ' B' ' 6' ' ' ILE . 35.6 Cg_endo -77.92 111.68 3.14 Favored 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 122.675 2.25 . . . . 1.99 110.196 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 176.63 -178.28 47.94 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.756 -1.338 . . . . 0.90000000000000002 109.756 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 60' ' ' LEU . . . . . 0.575 ' O ' ' CD1' ' B' ' 61' ' ' TYR . 0.1 OUTLIER -73.17 162.12 29.79 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.202 -1.176 . . . . 2.7799999999999998 107.993 179.106 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 61' ' ' TYR . . . . . 0.608 ' CE1' HD11 ' B' ' 6' ' ' ILE . 24.0 m-85 -147.49 164.46 33.31 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-O 122.43 1.109 . . . . 2.48 111.386 -179.182 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 62' ' ' THR . . . . . 0.526 ' CG2' ' SD ' ' B' ' 1' ' ' MET . 21.4 p -147.49 119.51 8.21 Favored 'General case' 0 C--N 1.292 -1.891 0 N-CA-C 106.236 -1.764 . . . . 3.4500000000000002 106.236 178.214 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 63' ' ' VAL . . . . . 0.585 ' CG1' ' HB2' ' B' ' 81' ' ' LEU . 10.1 t -52.59 169.18 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.286 -2.17 0 C-N-CA 118.556 -1.258 . . . . 2.54 108.673 -178.517 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 64' ' ' HIS . . . . . 0.494 ' CB ' ' O ' ' B' ' 82' ' ' ARG . 2.1 t-80 -132.31 127.42 35.56 Favored 'General case' 0 C--N 1.293 -1.851 0 O-C-N 121.412 -0.805 . . . . 3.8100000000000001 109.113 -179.211 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 65' ' ' LEU . . . . . 0.625 ' HB2' ' CD2' ' B' ' 68' ' ' PHE . 0.6 OUTLIER -72.78 1.9 7.68 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.398 -0.813 . . . . 4.1900000000000004 109.976 -179.994 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -57.18 -19.71 22.21 Favored 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 107.247 -1.39 . . . . 1.79 107.247 178.525 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 67' ' ' SER . . . . . 0.54 ' CB ' ' O ' ' B' ' 80' ' ' ARG . 47.8 m -95.74 -10.57 28.84 Favored 'General case' 0 N--CA 1.485 1.321 0 O-C-N 121.875 -0.516 . . . . 3.21 109.848 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 68' ' ' PHE . . . . . 0.625 ' CD2' ' HB2' ' B' ' 65' ' ' LEU . 2.8 m-30 -77.65 155.72 31.2 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.128 -0.982 . . . . 2.73 109.664 -179.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 69' ' ' LYS . . . . . 0.534 ' CA ' HD12 ' A' ' 37' ' ' LEU . 3.7 mtmt -150.27 164.98 34.36 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.361 -0.837 . . . . 2.6099999999999999 109.337 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 70' ' ' VAL . . . . . 0.526 ' CG1' HG22 ' A' ' 45' ' ' VAL . 1.7 t -97.95 117.6 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.322 -0.861 . . . . 2.02 109.118 179.739 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . -79.11 172.21 55.18 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.604 -1.398 . . . . 2.5299999999999998 109.604 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 72' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -77.1 1.02 19.36 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.141 -1.211 . . . . 6.7400000000000002 109.858 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -89.53 1.82 55.42 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 121.57 -0.706 . . . . 2.8999999999999999 109.294 179.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 74' ' ' GLY . . . . . 0.465 ' O ' ' HB2' ' A' ' 46' ' ' LYS . . . 70.23 50.31 28.28 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.552 -1.419 . . . . 2.6200000000000001 109.552 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 75' ' ' SER . . . . . 0.518 ' N ' HG23 ' A' ' 45' ' ' VAL . 40.5 m -161.44 127.79 3.84 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.152 -1.205 . . . . 2.7799999999999998 109.586 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 76' ' ' LEU . . . . . 0.523 ' O ' ' CG ' ' B' ' 77' ' ' MET . 0.3 OUTLIER -53.53 154.29 3.66 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.209 -0.932 . . . . 1.3400000000000001 109.345 179.948 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 77' ' ' MET . . . . . 0.523 ' CG ' ' O ' ' B' ' 76' ' ' LEU . 22.4 mtp -160.27 117.6 2.51 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.243 -0.911 . . . . 3.7599999999999998 109.47 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 78' ' ' ILE . . . . . 0.619 HG12 ' CE1' ' B' ' 68' ' ' PHE . 4.9 mt -59.17 134.39 24.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.33 -0.856 . . . . 1.52 109.617 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 79' ' ' ASP . . . . . 0.427 ' CG ' ' HE2' ' B' ' 69' ' ' LYS . 26.3 t70 -103.23 -21.04 13.91 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.239 -1.023 . . . . 2.3999999999999999 108.239 178.696 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 80' ' ' ARG . . . . . 0.54 ' O ' ' CB ' ' B' ' 67' ' ' SER . 0.0 OUTLIER 174.39 69.07 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 107.242 -1.392 . . . . 1.75 107.242 179.325 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 81' ' ' LEU . . . . . 0.585 ' HB2' ' CG1' ' B' ' 63' ' ' VAL . 0.8 OUTLIER -31.55 121.31 0.26 Allowed 'General case' 0 C--N 1.297 -1.696 0 CA-C-N 115.235 -0.893 . . . . 3.6200000000000001 111.818 -178.191 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 82' ' ' ARG . . . . . 0.494 ' O ' ' CB ' ' B' ' 64' ' ' HIS . 0.1 OUTLIER -90.69 104.31 16.91 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 107.962 -1.125 . . . . 8.0700000000000003 107.962 178.701 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 83' ' ' LEU . . . . . 0.606 ' HB3' ' CE2' ' B' ' 56' ' ' TYR . 0.5 OUTLIER -73.51 148.85 42.71 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.252 -0.905 . . . . 2.6899999999999999 111.099 -178.509 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 84' ' ' VAL . . . . . 0.522 ' CG2' ' O ' ' B' ' 62' ' ' THR . 24.9 m -148.73 156.22 41.39 Favored Pre-proline 0 C--N 1.302 -1.49 0 N-CA-C 107.853 -1.166 . . . . 2.8599999999999999 107.853 179.546 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 85' ' ' PRO . . . . . 0.507 ' HA ' ' O ' ' B' ' 60' ' ' LEU . 24.3 Cg_endo -62.54 147.77 94.33 Favored 'Trans proline' 0 C--N 1.304 -1.782 0 C-N-CA 122.102 1.868 . . . . 2.8599999999999999 110.612 178.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 86' ' ' ALA . . . . . 0.46 ' CA ' HG21 ' B' ' 62' ' ' THR . . . -87.13 130.33 34.57 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.187 -0.945 . . . . 3.6400000000000001 109.385 -178.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 117.945 -1.026 . . . . 8.9499999999999993 109.488 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.599 ' SD ' HG21 ' A' ' 62' ' ' THR . 26.5 ttm . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 121.37 0.605 . . . . 6.92 109.419 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.638 ' CA ' HD22 ' B' ' 65' ' ' LEU . 2.4 mt -76.91 80.9 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 N-CA-C 108.063 -1.088 . . . . 2.58 108.063 179.534 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.838 ' O ' HG13 ' A' ' 35' ' ' VAL . 36.6 mttt -64.05 177.23 0.82 Allowed 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 121.961 0.886 . . . . 2.83 111.705 -178.033 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 1.077 HG13 ' HB2' ' A' ' 61' ' ' TYR . 2.0 p 172.24 149.7 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 N-CA-C 108.84 -0.8 . . . . 3.97 108.84 179.8 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.545 ' O ' ' HB2' ' A' ' 34' ' ' TYR . 43.7 mt-10 -123.62 113.79 19.14 Favored 'General case' 0 C--N 1.293 -1.862 0 O-C-N 121.361 -0.837 . . . . 3.84 109.808 -179.718 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.788 HD13 ' HB3' ' A' ' 56' ' ' TYR . 0.2 OUTLIER -73.63 101.3 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 N-CA-C 107.794 -1.187 . . . . 1.47 107.794 179.001 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.68 ' HD3' ' CD2' ' A' ' 34' ' ' TYR . 0.0 OUTLIER -44.15 170.01 0.05 OUTLIER Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.403 -0.811 . . . . 2.41 110.013 -179.031 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.448 ' HD2' ' HB3' ' A' ' 7' ' ' LYS . 33.1 Cg_endo -74.69 -25.0 12.97 Favored 'Trans proline' 0 C--N 1.31 -1.486 0 C-N-CA 122.475 2.117 . . . . 2.71 109.746 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -90.01 -0.2 57.46 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 108.937 -0.764 . . . . 3.45 108.937 178.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.501 ' O ' ' NE2' ' A' ' 31' ' ' GLN . 6.2 mm-40 -118.42 38.23 3.79 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.278 -0.889 . . . . 4.63 109.225 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.418 ' O ' ' HB3' ' A' ' 55' ' ' ALA . . . -103.26 10.32 37.68 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.137 -0.977 . . . . 1.81 110.348 -179.275 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.432 ' HA ' ' CB ' ' A' ' 55' ' ' ALA . 34.5 mt-30 -136.63 135.8 38.61 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.047 -1.033 . . . . 5.65 110.05 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.656 ' CD1' ' HB3' ' A' ' 29' ' ' ASN . 28.5 p90 -86.13 170.9 11.77 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.387 -0.821 . . . . 2.95 109.497 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 96.6 m -136.75 151.16 48.89 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.395 -0.816 . . . . 4.44 108.952 179.162 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.03 112.63 22.05 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.251 -0.906 . . . . 2.89 109.419 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -129.45 147.71 51.29 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.302 -0.874 . . . . 9.22 109.397 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -54.38 106.98 0.23 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.237 -0.915 . . . . 3.53 109.427 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.57 ' HA3' ' CE1' ' A' ' 26' ' ' TYR . . . -104.9 165.31 14.45 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 109.425 -1.47 . . . . 6.14 109.425 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.422 ' C ' ' CE2' ' A' ' 26' ' ' TYR . 0.9 OUTLIER -135.99 115.07 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.166 -1.197 . . . . 9.27 108.937 179.435 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.473 ' N ' ' CE2' ' A' ' 26' ' ' TYR . 0.5 OUTLIER -46.91 -78.81 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.437 -0.79 . . . . 11.29 109.552 -179.258 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.486 ' O ' ' CB ' ' A' ' 22' ' ' GLN . 56.8 mtp180 -148.62 53.25 0.99 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.28 -0.887 . . . . 9.51 109.555 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.486 ' CB ' ' O ' ' A' ' 21' ' ' ARG . 5.2 mt-30 73.31 20.96 3.14 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.254 -0.904 . . . . 13.35 109.356 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.445 ' C ' ' CG ' ' A' ' 24' ' ' LYS . . . -106.21 -51.39 0.83 Allowed Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.499 -1.441 . . . . 7.9 109.499 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.445 ' CG ' ' C ' ' A' ' 23' ' ' GLY . 1.1 mttt -154.85 149.85 20.5 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.279 -1.13 . . . . 5.46 109.455 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -78.37 115.85 3.76 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.689 2.259 . . . . 5.38 110.231 179.63 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.605 ' O ' ' CD1' ' A' ' 26' ' ' TYR . 6.3 p90 -111.19 141.08 45.18 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.167 -0.958 . . . . 7.28 109.644 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -97.99 79.03 2.58 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.175 -0.953 . . . . 4.06 108.779 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.594 ' HB2' ' CD1' ' A' ' 26' ' ' TYR . 0.2 OUTLIER -92.41 170.68 9.58 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.229 -0.919 . . . . 7.71 110.292 -179.187 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.656 ' HB3' ' CD1' ' A' ' 13' ' ' PHE . 0.0 OUTLIER -92.97 121.95 34.84 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 108.637 -0.875 . . . . 4.9 108.637 179.505 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.476 ' O ' ' HA ' ' A' ' 13' ' ' PHE . 2.8 mt-10 -109.93 156.07 20.91 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.061 -1.024 . . . . 3.29 109.763 -179.461 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.646 ' HB2' HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -137.67 -169.26 2.5 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.227 -0.92 . . . . 3.28 109.771 179.972 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.889 ' HB3' HD11 ' A' ' 44' ' ' LEU . 1.2 mt -134.77 173.85 11.23 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.449 -0.782 . . . . 2.59 109.34 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.525 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -168.38 165.87 12.58 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 108.3 -1.0 . . . . 1.83 108.3 -179.856 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.944 ' C ' HG23 ' A' ' 4' ' ' VAL . 18.1 m-85 -119.55 96.7 5.31 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.036 -1.04 . . . . 3.34 109.472 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.928 ' O ' HG22 ' A' ' 43' ' ' VAL . 3.0 t -95.43 113.6 30.19 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 O-C-N 121.219 -0.926 . . . . 1.53 110.597 -179.446 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.44 ' O ' ' N ' ' A' ' 39' ' ' ASN . 1.4 m-20 -62.77 -35.47 79.92 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 107.023 -1.473 . . . . 3.99 107.023 178.139 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.713 HD11 ' C ' ' B' ' 68' ' ' PHE . 3.3 tt 48.98 21.4 0.46 Allowed 'General case' 0 N--CA 1.491 1.593 0 CA-C-O 121.62 0.724 . . . . 2.4 110.071 178.715 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 88.46 14.14 62.24 Favored Glycine 0 N--CA 1.48 1.626 0 N-CA-C 109.075 -1.61 . . . . 2.7 109.075 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.632 HD22 HG11 ' A' ' 43' ' ' VAL . 42.8 m-20 -94.7 12.95 25.99 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.371 -1.076 . . . . 3.51 109.777 -179.683 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.523 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 19.5 mt-10 70.68 -52.31 0.67 Allowed 'General case' 0 N--CA 1.498 1.97 0 CA-C-O 121.645 0.736 . . . . 4.1 110.363 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.48 ' HB3' ' HD2' ' A' ' 42' ' ' PRO . 18.1 m80 -97.71 161.52 25.5 Favored Pre-proline 0 C--N 1.291 -1.971 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.655 ' HB2' ' CD1' ' A' ' 34' ' ' TYR . 37.0 Cg_endo -77.72 138.06 16.65 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 C-N-CA 122.118 1.879 . . . . 3.45 110.257 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.928 HG22 ' O ' ' A' ' 35' ' ' VAL . 3.9 m -110.76 115.14 49.05 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 C-N-CA 119.425 -0.91 . . . . 3.58 109.207 179.381 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.889 HD11 ' HB3' ' A' ' 32' ' ' LEU . 60.9 tp -67.98 101.31 1.1 Allowed 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.213 -0.929 . . . . 2.65 109.01 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.764 HG22 ' C ' ' B' ' 74' ' ' GLY . 0.3 OUTLIER -110.44 157.94 10.95 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 N-CA-C 109.099 -0.704 . . . . 2.66 109.099 -179.552 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.457 ' HB2' ' O ' ' B' ' 74' ' ' GLY . 9.3 mtpt -81.49 172.62 13.29 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.072 -1.017 . . . . 3.89 110.187 -179.255 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.934 HD11 ' HB2' ' A' ' 83' ' ' LEU . 0.5 OUTLIER -159.91 154.19 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 N-CA-C 108.622 -0.881 . . . . 4.07 108.622 179.87 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.799 HG21 ' NH1' ' A' ' 80' ' ' ARG . 0.2 OUTLIER -94.86 149.02 21.69 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.978 -1.076 . . . . 3.44 109.529 -179.993 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.702 HD21 ' HA ' ' A' ' 55' ' ' ALA . 0.2 OUTLIER -119.11 113.13 20.43 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.802 -0.814 . . . . 4.57 108.802 179.873 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.432 ' O ' ' ND2' ' A' ' 29' ' ' ASN . 0.1 OUTLIER -53.4 149.79 7.22 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.242 -0.911 . . . . 4.77 109.864 -179.43 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -63.09 117.45 6.51 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.309 -0.87 . . . . 6.49 109.348 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 96.06 -18.36 57.58 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.456 -1.457 . . . . 4.1 109.456 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -75.13 144.32 78.72 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.239 -1.153 . . . . 3.06 109.28 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.442 ' O ' ' C ' ' A' ' 55' ' ' ALA . 35.4 Cg_endo -78.25 123.64 6.2 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.563 2.175 . . . . 3.16 110.53 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.702 ' HA ' HD21 ' A' ' 49' ' ' LEU . . . -41.15 146.78 0.16 Allowed 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.411 -0.806 . . . . 1.73 110.092 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.788 ' HB3' HD13 ' A' ' 6' ' ' ILE . 87.1 m-85 -47.65 99.34 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.358 -0.839 . . . . 2.44 108.888 179.649 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.837 ' HB1' ' HD2' ' A' ' 58' ' ' PRO . . . -47.37 171.79 0.07 OUTLIER Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.253 -0.904 . . . . 1.16 109.557 -179.764 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.837 ' HD2' ' HB1' ' A' ' 57' ' ' ALA . 35.2 Cg_endo -78.03 112.24 3.22 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 122.656 2.238 . . . . 1.99 110.277 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 175.62 -178.14 47.25 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.645 -1.382 . . . . 0.91 109.645 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.877 ' HB3' ' HB3' ' A' ' 86' ' ' ALA . 0.1 OUTLIER -73.02 162.2 29.77 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.245 -1.15 . . . . 2.78 108.191 179.307 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 1.077 ' HB2' HG13 ' A' ' 4' ' ' VAL . 23.2 m-85 -147.49 164.56 33.0 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-O 122.45 1.119 . . . . 2.48 111.437 -179.184 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.861 ' O ' HG22 ' A' ' 84' ' ' VAL . 21.2 p -147.64 119.37 8.06 Favored 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 106.299 -1.741 . . . . 3.45 106.299 178.26 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.6 ' CG1' ' HB2' ' A' ' 81' ' ' LEU . 10.0 t -52.55 169.18 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.286 -2.175 0 C-N-CA 118.495 -1.282 . . . . 2.54 108.708 -178.498 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.536 ' H ' HG12 ' A' ' 63' ' ' VAL . 2.1 t-80 -132.32 127.36 35.4 Favored 'General case' 0 C--N 1.293 -1.876 0 O-C-N 121.443 -0.785 . . . . 3.81 109.127 -179.213 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.656 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 0.6 OUTLIER -72.73 1.82 7.74 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.385 -0.822 . . . . 4.2 109.976 -179.961 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -57.2 -19.67 22.29 Favored 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 107.287 -1.375 . . . . 1.79 107.287 178.553 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.528 ' CB ' ' O ' ' A' ' 80' ' ' ARG . 48.5 m -95.67 -10.38 29.51 Favored 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.84 -0.537 . . . . 3.21 109.798 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.723 ' C ' HD11 ' B' ' 37' ' ' LEU . 2.8 m-30 -77.88 155.89 30.68 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.136 -0.977 . . . . 2.73 109.772 -178.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.48 ' HG2' ' O ' ' A' ' 68' ' ' PHE . 3.7 mtmt -150.45 165.01 34.47 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.369 -0.832 . . . . 2.61 109.334 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.906 HG21 HG21 ' B' ' 43' ' ' VAL . 1.7 t -97.91 117.59 42.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.312 -0.868 . . . . 2.02 109.133 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -79.16 172.2 55.15 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.585 -1.406 . . . . 2.53 109.585 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -77.04 1.02 19.15 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.096 -1.238 . . . . 6.73 109.893 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -89.49 1.75 55.48 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 121.544 -0.723 . . . . 2.9 109.347 179.69 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.747 ' C ' HG22 ' B' ' 45' ' ' VAL . . . 70.31 50.35 27.58 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.508 -1.437 . . . . 2.62 109.508 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.611 ' N ' HG22 ' B' ' 45' ' ' VAL . 40.5 m -161.52 127.81 3.81 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.113 -1.228 . . . . 2.78 109.547 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.58 HD11 HD12 ' B' ' 37' ' ' LEU . 0.3 OUTLIER -53.48 154.32 3.58 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.232 -0.918 . . . . 1.34 109.323 179.937 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 77' ' ' MET . . . . . 0.531 ' CG ' ' O ' ' A' ' 76' ' ' LEU . 22.4 mtp -160.29 117.49 2.49 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.228 -0.92 . . . . 3.76 109.474 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.638 HG12 ' CE1' ' A' ' 68' ' ' PHE . 4.9 mt -59.01 134.35 24.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.29 -0.881 . . . . 1.52 109.565 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.45 ' CG ' ' HE2' ' A' ' 69' ' ' LYS . 26.5 t70 -103.22 -21.13 13.9 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.285 -1.005 . . . . 2.41 108.285 178.705 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.799 ' NH1' HG21 ' A' ' 48' ' ' THR . 0.0 OUTLIER 174.47 68.95 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 107.304 -1.369 . . . . 1.75 107.304 179.357 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.649 ' O ' HD23 ' A' ' 81' ' ' LEU . 0.9 OUTLIER -31.48 121.35 0.25 Allowed 'General case' 0 C--N 1.297 -1.693 0 CA-C-N 115.285 -0.87 . . . . 3.62 111.797 -178.151 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.49 ' O ' ' CB ' ' A' ' 64' ' ' HIS . 0.1 OUTLIER -90.7 104.24 16.85 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.004 -1.11 . . . . 8.07 108.004 178.678 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.934 ' HB2' HD11 ' A' ' 47' ' ' ILE . 0.5 OUTLIER -73.47 148.85 42.8 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.271 -0.893 . . . . 2.69 111.099 -178.474 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.861 HG22 ' O ' ' A' ' 62' ' ' THR . 25.0 m -148.79 156.12 41.2 Favored Pre-proline 0 C--N 1.302 -1.49 0 N-CA-C 107.872 -1.159 . . . . 2.86 107.872 179.498 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.575 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 24.1 Cg_endo -62.42 147.84 94.25 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 C-N-CA 122.022 1.814 . . . . 2.86 110.604 179.035 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.877 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . . . -87.13 130.39 34.54 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.179 -0.951 . . . . 3.64 109.421 -178.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.509 0 CA-C-O 118.0 -1.0 . . . . 8.95 109.531 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.597 ' SD ' HG21 ' B' ' 62' ' ' THR . 26.4 ttm . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 121.397 0.617 . . . . 6.92 109.38 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 2' ' ' ILE . . . . . 0.648 ' CA ' HD22 ' A' ' 65' ' ' LEU . 2.4 mt -76.98 80.83 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 N-CA-C 108.025 -1.102 . . . . 2.57 108.025 179.582 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 3' ' ' LYS . . . . . 0.831 ' O ' HG13 ' B' ' 35' ' ' VAL . 36.7 mttt -64.02 177.17 0.83 Allowed 'General case' 0 N--CA 1.493 1.698 0 CA-C-O 121.964 0.888 . . . . 2.83 111.674 -178.061 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 4' ' ' VAL . . . . . 1.076 HG13 ' HB2' ' B' ' 61' ' ' TYR . 2.0 p 172.27 149.74 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 N-CA-C 108.807 -0.812 . . . . 3.97 108.807 179.836 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 5' ' ' GLU . . . . . 0.545 ' O ' ' HB2' ' B' ' 34' ' ' TYR . 44.2 mt-10 -123.67 113.8 19.12 Favored 'General case' 0 C--N 1.292 -1.903 0 O-C-N 121.336 -0.853 . . . . 3.84 109.789 -179.736 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 6' ' ' ILE . . . . . 0.802 HD13 ' HB3' ' B' ' 56' ' ' TYR . 0.2 OUTLIER -73.64 101.32 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 N-CA-C 107.757 -1.201 . . . . 1.47 107.757 179.004 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 7' ' ' LYS . . . . . 0.672 ' HD3' ' CD2' ' B' ' 34' ' ' TYR . 0.0 OUTLIER -44.14 170.03 0.05 OUTLIER Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.386 -0.821 . . . . 2.41 110.013 -179.06 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 8' ' ' PRO . . . . . 0.46 ' HD2' ' HB3' ' B' ' 7' ' ' LYS . 33.2 Cg_endo -74.66 -25.06 12.97 Favored 'Trans proline' 0 C--N 1.311 -1.443 0 C-N-CA 122.415 2.077 . . . . 2.71 109.813 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -89.91 -0.27 57.47 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 108.93 -0.767 . . . . 3.45 108.93 178.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 10' ' ' GLN . . . . . 0.503 ' O ' ' NE2' ' B' ' 31' ' ' GLN . 6.2 mm-40 -118.38 38.25 3.78 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.325 -0.859 . . . . 4.63 109.25 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 11' ' ' ALA . . . . . 0.417 ' O ' ' HB3' ' B' ' 55' ' ' ALA . . . -103.3 10.35 37.6 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.124 -0.985 . . . . 1.81 110.333 -179.245 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 12' ' ' GLN . . . . . 0.426 ' HA ' ' CB ' ' B' ' 55' ' ' ALA . 34.5 mt-30 -136.67 135.71 38.46 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.044 -1.035 . . . . 5.66 110.036 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 13' ' ' PHE . . . . . 0.643 ' CD1' ' HB3' ' B' ' 29' ' ' ASN . 28.6 p90 -86.05 170.83 11.89 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.409 -0.807 . . . . 2.95 109.519 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 96.6 m -136.73 151.15 48.9 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.378 -0.826 . . . . 4.44 108.972 179.16 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.06 112.66 22.09 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.239 -0.913 . . . . 2.89 109.41 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -129.47 147.71 51.31 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.328 -0.858 . . . . 9.22 109.376 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -54.43 107.02 0.24 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.277 -0.89 . . . . 3.53 109.429 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 18' ' ' GLY . . . . . 0.582 ' HA3' ' CE1' ' B' ' 26' ' ' TYR . . . -104.89 165.29 14.46 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.418 -1.473 . . . . 6.14 109.418 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 19' ' ' VAL . . . . . 0.423 ' C ' ' CE2' ' B' ' 26' ' ' TYR . 0.9 OUTLIER -135.98 115.1 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.188 -1.184 . . . . 9.27 108.91 179.429 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 20' ' ' SER . . . . . 0.471 ' N ' ' CE2' ' B' ' 26' ' ' TYR . 0.5 OUTLIER -46.91 -78.85 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.394 -0.816 . . . . 11.3 109.552 -179.313 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 21' ' ' ARG . . . . . 0.465 ' O ' ' CB ' ' B' ' 22' ' ' GLN . 56.9 mtp180 -148.56 53.17 1.0 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.272 -0.892 . . . . 9.52 109.6 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 22' ' ' GLN . . . . . 0.465 ' CB ' ' O ' ' B' ' 21' ' ' ARG . 5.2 mt-30 73.38 20.98 3.09 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.176 -0.952 . . . . 13.35 109.323 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 23' ' ' GLY . . . . . 0.445 ' C ' ' CG ' ' B' ' 24' ' ' LYS . . . -106.22 -51.37 0.83 Allowed Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.534 -1.426 . . . . 7.9 109.534 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 24' ' ' LYS . . . . . 0.445 ' CG ' ' C ' ' B' ' 23' ' ' GLY . 1.1 mttt -154.86 149.78 20.38 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.203 -1.175 . . . . 5.46 109.541 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -78.28 115.77 3.77 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 122.727 2.284 . . . . 5.38 110.316 179.589 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 26' ' ' TYR . . . . . 0.603 ' CD1' ' O ' ' B' ' 26' ' ' TYR . 6.3 p90 -111.08 141.07 45.06 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.127 -0.983 . . . . 7.28 109.718 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 27' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -98.03 78.97 2.56 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.148 -0.97 . . . . 4.06 108.727 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 28' ' ' LEU . . . . . 0.599 ' HB2' ' CE1' ' B' ' 26' ' ' TYR . 0.2 OUTLIER -92.39 170.64 9.62 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.195 -0.94 . . . . 7.71 110.298 -179.197 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 29' ' ' ASN . . . . . 0.643 ' HB3' ' CD1' ' B' ' 13' ' ' PHE . 0.0 OUTLIER -92.92 121.92 34.76 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.623 -0.88 . . . . 4.9 108.623 179.559 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 30' ' ' GLU . . . . . 0.459 ' O ' ' HA ' ' B' ' 13' ' ' PHE . 2.8 mt-10 -109.94 156.05 20.95 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.097 -1.002 . . . . 3.29 109.77 -179.45 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 31' ' ' GLN . . . . . 0.627 ' HB2' HD23 ' B' ' 49' ' ' LEU . 0.0 OUTLIER -137.63 -169.26 2.49 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.25 -0.906 . . . . 3.28 109.829 179.948 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 32' ' ' LEU . . . . . 0.896 ' HB3' HD11 ' B' ' 44' ' ' LEU . 1.2 mt -134.74 173.86 11.21 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.429 -0.794 . . . . 2.59 109.34 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 33' ' ' CYS . . . . . 0.527 ' HB2' HG21 ' B' ' 4' ' ' VAL . 0.0 OUTLIER -168.36 165.94 12.6 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.058 -1.026 . . . . 1.83 108.274 -179.812 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 34' ' ' TYR . . . . . 0.934 ' C ' HG23 ' B' ' 4' ' ' VAL . 17.8 m-85 -119.66 96.66 5.28 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.053 -1.029 . . . . 3.34 109.438 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 35' ' ' VAL . . . . . 0.914 ' O ' HG22 ' B' ' 43' ' ' VAL . 2.9 t -95.37 113.65 30.24 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 O-C-N 121.196 -0.94 . . . . 1.52 110.658 -179.469 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 36' ' ' ASP . . . . . 0.437 ' O ' ' N ' ' B' ' 39' ' ' ASN . 1.4 m-20 -62.82 -35.53 80.2 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 106.989 -1.486 . . . . 3.99 106.989 178.174 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 37' ' ' LEU . . . . . 0.723 HD11 ' C ' ' A' ' 68' ' ' PHE . 3.3 tt 49.09 21.35 0.48 Allowed 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 121.614 0.721 . . . . 2.4 110.039 178.698 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 88.35 14.33 62.16 Favored Glycine 0 N--CA 1.482 1.701 0 N-CA-C 109.094 -1.602 . . . . 2.7 109.094 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 39' ' ' ASN . . . . . 0.636 HD22 HG11 ' B' ' 43' ' ' VAL . 42.2 m-20 -94.74 12.89 26.3 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.333 -1.098 . . . . 3.51 109.82 -179.756 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 40' ' ' GLU . . . . . 0.525 ' HB2' ' O ' ' B' ' 39' ' ' ASN . 19.5 mt-10 70.61 -52.36 0.66 Allowed 'General case' 0 N--CA 1.499 1.995 0 CA-C-O 121.663 0.744 . . . . 4.11 110.356 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 41' ' ' HIS . . . . . 0.481 ' HB3' ' HD2' ' B' ' 42' ' ' PRO . 18.3 m80 -97.59 161.58 25.38 Favored Pre-proline 0 C--N 1.291 -1.974 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 42' ' ' PRO . . . . . 0.661 ' HB2' ' CD1' ' B' ' 34' ' ' TYR . 37.0 Cg_endo -77.83 137.99 16.38 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 122.068 1.845 . . . . 3.44 110.287 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 43' ' ' VAL . . . . . 0.914 HG22 ' O ' ' B' ' 35' ' ' VAL . 3.9 m -110.66 115.17 49.11 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 O-C-N 121.221 -0.924 . . . . 3.58 109.207 179.421 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 44' ' ' LEU . . . . . 0.896 HD11 ' HB3' ' B' ' 32' ' ' LEU . 60.7 tp -68.03 101.26 1.1 Allowed 'General case' 0 C--N 1.302 -1.496 0 C-N-CA 119.331 -0.948 . . . . 2.65 109.056 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 45' ' ' VAL . . . . . 0.747 HG22 ' C ' ' A' ' 74' ' ' GLY . 0.3 OUTLIER -110.37 157.94 10.85 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 N-CA-C 109.121 -0.696 . . . . 2.66 109.121 -179.48 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 46' ' ' LYS . . . . . 0.461 ' HB2' ' O ' ' A' ' 74' ' ' GLY . 9.3 mtpt -81.52 172.63 13.25 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.087 -1.008 . . . . 3.89 110.177 -179.252 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 47' ' ' ILE . . . . . 0.945 HD13 HD12 ' B' ' 83' ' ' LEU . 0.5 OUTLIER -159.83 154.29 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 N-CA-C 108.728 -0.842 . . . . 4.07 108.728 179.814 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 48' ' ' THR . . . . . 0.801 HG21 ' NH1' ' B' ' 80' ' ' ARG . 0.2 OUTLIER -95.0 149.02 21.7 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.03 -1.044 . . . . 3.44 109.579 -179.998 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 49' ' ' LEU . . . . . 0.703 HD21 ' HA ' ' B' ' 55' ' ' ALA . 0.2 OUTLIER -119.1 113.13 20.44 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.802 -0.814 . . . . 4.57 108.802 179.932 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 50' ' ' ASP . . . . . 0.455 ' O ' ' ND2' ' B' ' 29' ' ' ASN . 0.1 OUTLIER -53.36 149.8 7.1 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.242 -0.911 . . . . 4.77 109.941 -179.455 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -63.12 117.44 6.51 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.355 -0.841 . . . . 6.49 109.404 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . 96.06 -18.32 57.66 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.456 -1.457 . . . . 4.11 109.456 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -75.22 144.3 78.35 Favored Pre-proline 0 N--CA 1.488 1.44 0 O-C-N 121.176 -1.19 . . . . 3.06 109.318 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 54' ' ' PRO . . . . . 0.424 ' O ' ' C ' ' B' ' 55' ' ' ALA . 35.5 Cg_endo -78.28 123.65 6.18 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.578 2.185 . . . . 3.16 110.566 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 55' ' ' ALA . . . . . 0.703 ' HA ' HD21 ' B' ' 49' ' ' LEU . . . -41.07 146.69 0.16 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.338 -0.851 . . . . 1.73 110.152 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 56' ' ' TYR . . . . . 0.802 ' HB3' HD13 ' B' ' 6' ' ' ILE . 87.7 m-85 -47.58 98.08 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.376 -0.827 . . . . 2.45 109.004 179.725 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 57' ' ' ALA . . . . . 0.864 ' HB1' ' HD2' ' B' ' 58' ' ' PRO . . . -46.2 171.75 0.06 OUTLIER Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.187 -0.945 . . . . 1.16 109.698 -179.513 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 58' ' ' PRO . . . . . 0.864 ' HD2' ' HB1' ' B' ' 57' ' ' ALA . 35.6 Cg_endo -77.92 111.68 3.14 Favored 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 122.675 2.25 . . . . 1.99 110.196 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 176.63 -178.28 47.94 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.756 -1.338 . . . . 0.9 109.756 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 60' ' ' LEU . . . . . 0.851 ' HB3' ' HB3' ' B' ' 86' ' ' ALA . 0.1 OUTLIER -73.17 162.12 29.79 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.202 -1.176 . . . . 2.78 107.993 179.106 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 61' ' ' TYR . . . . . 1.076 ' HB2' HG13 ' B' ' 4' ' ' VAL . 24.0 m-85 -147.49 164.46 33.31 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-O 122.43 1.109 . . . . 2.48 111.386 -179.182 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 62' ' ' THR . . . . . 0.865 ' O ' HG22 ' B' ' 84' ' ' VAL . 21.4 p -147.49 119.51 8.21 Favored 'General case' 0 C--N 1.292 -1.891 0 N-CA-C 106.236 -1.764 . . . . 3.45 106.236 178.214 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 63' ' ' VAL . . . . . 0.593 ' CG1' ' HB2' ' B' ' 81' ' ' LEU . 10.1 t -52.59 169.18 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.286 -2.17 0 C-N-CA 118.556 -1.258 . . . . 2.54 108.673 -178.517 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 64' ' ' HIS . . . . . 0.54 ' H ' HG12 ' B' ' 63' ' ' VAL . 2.1 t-80 -132.31 127.42 35.56 Favored 'General case' 0 C--N 1.293 -1.851 0 O-C-N 121.412 -0.805 . . . . 3.81 109.113 -179.211 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 65' ' ' LEU . . . . . 0.648 ' HB2' ' CD2' ' B' ' 68' ' ' PHE . 0.6 OUTLIER -72.78 1.9 7.68 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.398 -0.813 . . . . 4.19 109.976 -179.994 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -57.18 -19.71 22.21 Favored 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 107.247 -1.39 . . . . 1.79 107.247 178.525 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 67' ' ' SER . . . . . 0.54 ' CB ' ' O ' ' B' ' 80' ' ' ARG . 47.8 m -95.74 -10.57 28.84 Favored 'General case' 0 N--CA 1.485 1.321 0 O-C-N 121.875 -0.516 . . . . 3.21 109.848 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 68' ' ' PHE . . . . . 0.713 ' C ' HD11 ' A' ' 37' ' ' LEU . 2.8 m-30 -77.65 155.72 31.2 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.128 -0.982 . . . . 2.73 109.664 -179.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 69' ' ' LYS . . . . . 0.472 ' HG2' ' O ' ' B' ' 68' ' ' PHE . 3.7 mtmt -150.27 164.98 34.36 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.361 -0.837 . . . . 2.61 109.337 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 70' ' ' VAL . . . . . 0.88 HG21 HG21 ' A' ' 43' ' ' VAL . 1.7 t -97.95 117.6 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.322 -0.861 . . . . 2.02 109.118 179.739 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . -79.11 172.21 55.18 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.604 -1.398 . . . . 2.53 109.604 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 72' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -77.1 1.02 19.36 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.141 -1.211 . . . . 6.74 109.858 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -89.53 1.82 55.42 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 121.57 -0.706 . . . . 2.9 109.294 179.733 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 74' ' ' GLY . . . . . 0.764 ' C ' HG22 ' A' ' 45' ' ' VAL . . . 70.23 50.31 28.28 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.552 -1.419 . . . . 2.62 109.552 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 75' ' ' SER . . . . . 0.62 ' N ' HG22 ' A' ' 45' ' ' VAL . 40.5 m -161.44 127.79 3.84 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.152 -1.205 . . . . 2.78 109.586 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 76' ' ' LEU . . . . . 0.585 HD11 HD12 ' A' ' 37' ' ' LEU . 0.3 OUTLIER -53.53 154.29 3.66 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.209 -0.932 . . . . 1.34 109.345 179.948 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 77' ' ' MET . . . . . 0.523 ' CG ' ' O ' ' B' ' 76' ' ' LEU . 22.4 mtp -160.27 117.6 2.51 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.243 -0.911 . . . . 3.76 109.47 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 78' ' ' ILE . . . . . 0.638 HG12 ' CE1' ' B' ' 68' ' ' PHE . 4.9 mt -59.17 134.39 24.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.33 -0.856 . . . . 1.52 109.617 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 79' ' ' ASP . . . . . 0.449 ' CG ' ' HE2' ' B' ' 69' ' ' LYS . 26.3 t70 -103.23 -21.04 13.91 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.239 -1.023 . . . . 2.4 108.239 178.696 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 80' ' ' ARG . . . . . 0.801 ' NH1' HG21 ' B' ' 48' ' ' THR . 0.0 OUTLIER 174.39 69.07 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 107.242 -1.392 . . . . 1.75 107.242 179.325 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 81' ' ' LEU . . . . . 0.654 HD23 ' O ' ' B' ' 81' ' ' LEU . 0.8 OUTLIER -31.55 121.31 0.26 Allowed 'General case' 0 C--N 1.297 -1.696 0 CA-C-N 115.235 -0.893 . . . . 3.62 111.818 -178.191 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 82' ' ' ARG . . . . . 0.494 ' O ' ' CB ' ' B' ' 64' ' ' HIS . 0.1 OUTLIER -90.69 104.31 16.91 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 107.962 -1.125 . . . . 8.07 107.962 178.701 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 83' ' ' LEU . . . . . 0.945 HD12 HD13 ' B' ' 47' ' ' ILE . 0.5 OUTLIER -73.51 148.85 42.71 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.252 -0.905 . . . . 2.69 111.099 -178.509 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 84' ' ' VAL . . . . . 0.865 HG22 ' O ' ' B' ' 62' ' ' THR . 24.9 m -148.73 156.22 41.39 Favored Pre-proline 0 C--N 1.302 -1.49 0 N-CA-C 107.853 -1.166 . . . . 2.86 107.853 179.546 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 85' ' ' PRO . . . . . 0.575 ' HA ' ' O ' ' B' ' 60' ' ' LEU . 24.3 Cg_endo -62.54 147.77 94.33 Favored 'Trans proline' 0 C--N 1.304 -1.782 0 C-N-CA 122.102 1.868 . . . . 2.86 110.612 178.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 86' ' ' ALA . . . . . 0.851 ' HB3' ' HB3' ' B' ' 60' ' ' LEU . . . -87.13 130.33 34.57 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.187 -0.945 . . . . 3.64 109.385 -178.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 117.945 -1.026 . . . . 8.95 109.488 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.599 ' SD ' HG21 ' A' ' 62' ' ' THR . 26.5 ttm . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 121.37 0.605 . . . . 6.92 109.419 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.638 ' CA ' HD22 ' B' ' 65' ' ' LEU . 2.4 mt -76.91 80.9 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 N-CA-C 108.063 -1.088 . . . . 2.58 108.063 179.534 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.838 ' O ' HG13 ' A' ' 35' ' ' VAL . 36.6 mttt -64.05 177.23 0.82 Allowed 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 121.961 0.886 . . . . 2.83 111.705 -178.033 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 1.077 HG13 ' HB2' ' A' ' 61' ' ' TYR . 2.0 p 172.24 149.7 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 N-CA-C 108.84 -0.8 . . . . 3.97 108.84 179.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.545 ' O ' ' HB2' ' A' ' 34' ' ' TYR . 43.7 mt-10 -123.62 113.79 19.14 Favored 'General case' 0 C--N 1.293 -1.862 0 O-C-N 121.361 -0.837 . . . . 3.84 109.808 -179.718 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.788 HD13 ' HB3' ' A' ' 56' ' ' TYR . 0.2 OUTLIER -73.63 101.3 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 N-CA-C 107.794 -1.187 . . . . 1.47 107.794 179.001 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.68 ' HD3' ' CD2' ' A' ' 34' ' ' TYR . 0.0 OUTLIER -44.15 170.01 0.05 OUTLIER Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.403 -0.811 . . . . 2.41 110.013 -179.031 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.448 ' HD2' ' HB3' ' A' ' 7' ' ' LYS . 33.1 Cg_endo -74.69 -25.0 12.97 Favored 'Trans proline' 0 C--N 1.31 -1.486 0 C-N-CA 122.475 2.117 . . . . 2.71 109.746 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -90.01 -0.2 57.46 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 108.937 -0.764 . . . . 3.45 108.937 178.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.501 ' O ' ' NE2' ' A' ' 31' ' ' GLN . 6.2 mm-40 -118.42 38.23 3.79 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.278 -0.889 . . . . 4.63 109.225 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.418 ' O ' ' HB3' ' A' ' 55' ' ' ALA . . . -103.26 10.32 37.68 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.137 -0.977 . . . . 1.81 110.348 -179.275 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.432 ' HA ' ' CB ' ' A' ' 55' ' ' ALA . 34.5 mt-30 -136.63 135.8 38.61 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.047 -1.033 . . . . 5.65 110.05 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.656 ' CD1' ' HB3' ' A' ' 29' ' ' ASN . 28.5 p90 -86.13 170.9 11.77 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.387 -0.821 . . . . 2.95 109.497 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 96.6 m -136.75 151.16 48.89 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.395 -0.816 . . . . 4.44 108.952 179.162 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.03 112.63 22.05 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.251 -0.906 . . . . 2.89 109.419 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -129.45 147.71 51.29 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.302 -0.874 . . . . 9.22 109.397 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -54.38 106.98 0.23 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.237 -0.915 . . . . 3.53 109.427 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.57 ' HA3' ' CE1' ' A' ' 26' ' ' TYR . . . -104.9 165.31 14.45 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 109.425 -1.47 . . . . 6.14 109.425 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.422 ' C ' ' CE2' ' A' ' 26' ' ' TYR . 0.9 OUTLIER -135.99 115.07 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.166 -1.197 . . . . 9.27 108.937 179.435 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.473 ' N ' ' CE2' ' A' ' 26' ' ' TYR . 0.5 OUTLIER -46.91 -78.81 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.437 -0.79 . . . . 11.29 109.552 -179.258 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.486 ' O ' ' CB ' ' A' ' 22' ' ' GLN . 56.8 mtp180 -148.62 53.25 0.99 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.28 -0.887 . . . . 9.51 109.555 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.486 ' CB ' ' O ' ' A' ' 21' ' ' ARG . 5.2 mt-30 73.31 20.96 3.14 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.254 -0.904 . . . . 13.35 109.356 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.445 ' C ' ' CG ' ' A' ' 24' ' ' LYS . . . -106.21 -51.39 0.83 Allowed Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.499 -1.441 . . . . 7.9 109.499 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.445 ' CG ' ' C ' ' A' ' 23' ' ' GLY . 1.1 mttt -154.85 149.85 20.5 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.279 -1.13 . . . . 5.46 109.455 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -78.37 115.85 3.76 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.689 2.259 . . . . 5.38 110.231 179.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.605 ' O ' ' CD1' ' A' ' 26' ' ' TYR . 6.3 p90 -111.19 141.08 45.18 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.167 -0.958 . . . . 7.28 109.644 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -97.99 79.03 2.58 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.175 -0.953 . . . . 4.06 108.779 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.594 ' HB2' ' CD1' ' A' ' 26' ' ' TYR . 0.2 OUTLIER -92.41 170.68 9.58 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.229 -0.919 . . . . 7.71 110.292 -179.187 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.656 ' HB3' ' CD1' ' A' ' 13' ' ' PHE . 0.0 OUTLIER -92.97 121.95 34.84 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 108.637 -0.875 . . . . 4.9 108.637 179.505 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.476 ' O ' ' HA ' ' A' ' 13' ' ' PHE . 2.8 mt-10 -109.93 156.07 20.91 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.061 -1.024 . . . . 3.29 109.763 -179.461 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.646 ' HB2' HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -137.67 -169.26 2.5 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.227 -0.92 . . . . 3.28 109.771 179.972 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.889 ' HB3' HD11 ' A' ' 44' ' ' LEU . 1.2 mt -134.77 173.85 11.23 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.449 -0.782 . . . . 2.59 109.34 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.525 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -168.38 165.87 12.58 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 108.3 -1.0 . . . . 1.83 108.3 -179.856 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.944 ' C ' HG23 ' A' ' 4' ' ' VAL . 18.1 m-85 -119.55 96.7 5.31 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.036 -1.04 . . . . 3.34 109.472 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.928 ' O ' HG22 ' A' ' 43' ' ' VAL . 3.0 t -95.43 113.6 30.19 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 O-C-N 121.219 -0.926 . . . . 1.53 110.597 -179.446 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.44 ' O ' ' N ' ' A' ' 39' ' ' ASN . 1.4 m-20 -62.77 -35.47 79.92 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 107.023 -1.473 . . . . 3.99 107.023 178.139 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.713 HD11 ' C ' ' B' ' 68' ' ' PHE . 3.3 tt 48.98 21.4 0.46 Allowed 'General case' 0 N--CA 1.491 1.593 0 CA-C-O 121.62 0.724 . . . . 2.4 110.071 178.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 88.46 14.14 62.24 Favored Glycine 0 N--CA 1.48 1.626 0 N-CA-C 109.075 -1.61 . . . . 2.7 109.075 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.632 HD22 HG11 ' A' ' 43' ' ' VAL . 42.8 m-20 -94.7 12.95 25.99 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.371 -1.076 . . . . 3.51 109.777 -179.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.523 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 19.5 mt-10 70.68 -52.31 0.67 Allowed 'General case' 0 N--CA 1.498 1.97 0 CA-C-O 121.645 0.736 . . . . 4.1 110.363 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.48 ' HB3' ' HD2' ' A' ' 42' ' ' PRO . 18.1 m80 -97.71 161.52 25.5 Favored Pre-proline 0 C--N 1.291 -1.971 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.655 ' HB2' ' CD1' ' A' ' 34' ' ' TYR . 37.0 Cg_endo -77.72 138.06 16.65 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 C-N-CA 122.118 1.879 . . . . 3.45 110.257 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.928 HG22 ' O ' ' A' ' 35' ' ' VAL . 3.9 m -110.76 115.14 49.05 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 C-N-CA 119.425 -0.91 . . . . 3.58 109.207 179.381 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.889 HD11 ' HB3' ' A' ' 32' ' ' LEU . 60.9 tp -67.98 101.31 1.1 Allowed 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.213 -0.929 . . . . 2.65 109.01 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.764 HG22 ' C ' ' B' ' 74' ' ' GLY . 0.3 OUTLIER -110.44 157.94 10.95 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 N-CA-C 109.099 -0.704 . . . . 2.66 109.099 -179.552 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.457 ' HB2' ' O ' ' B' ' 74' ' ' GLY . 9.3 mtpt -81.49 172.62 13.29 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.072 -1.017 . . . . 3.89 110.187 -179.255 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.934 HD11 ' HB2' ' A' ' 83' ' ' LEU . 0.5 OUTLIER -159.91 154.19 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 N-CA-C 108.622 -0.881 . . . . 4.07 108.622 179.87 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.799 HG21 ' NH1' ' A' ' 80' ' ' ARG . 0.2 OUTLIER -94.86 149.02 21.69 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.978 -1.076 . . . . 3.44 109.529 -179.993 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.702 HD21 ' HA ' ' A' ' 55' ' ' ALA . 0.2 OUTLIER -119.11 113.13 20.43 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.802 -0.814 . . . . 4.57 108.802 179.873 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.432 ' O ' ' ND2' ' A' ' 29' ' ' ASN . 0.1 OUTLIER -53.4 149.79 7.22 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.242 -0.911 . . . . 4.77 109.864 -179.43 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -63.09 117.45 6.51 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.309 -0.87 . . . . 6.49 109.348 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 96.06 -18.36 57.58 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.456 -1.457 . . . . 4.1 109.456 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -75.13 144.32 78.72 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.239 -1.153 . . . . 3.06 109.28 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.442 ' O ' ' C ' ' A' ' 55' ' ' ALA . 35.4 Cg_endo -78.25 123.64 6.2 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.563 2.175 . . . . 3.16 110.53 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.702 ' HA ' HD21 ' A' ' 49' ' ' LEU . . . -41.15 146.78 0.16 Allowed 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.411 -0.806 . . . . 1.73 110.092 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.788 ' HB3' HD13 ' A' ' 6' ' ' ILE . 87.1 m-85 -47.65 99.34 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.358 -0.839 . . . . 2.44 108.888 179.649 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.837 ' HB1' ' HD2' ' A' ' 58' ' ' PRO . . . -47.37 171.79 0.07 OUTLIER Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.253 -0.904 . . . . 1.16 109.557 -179.764 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.837 ' HD2' ' HB1' ' A' ' 57' ' ' ALA . 35.2 Cg_endo -78.03 112.24 3.22 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 122.656 2.238 . . . . 1.99 110.277 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 175.62 -178.14 47.25 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.645 -1.382 . . . . 0.91 109.645 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.877 ' HB3' ' HB3' ' A' ' 86' ' ' ALA . 0.1 OUTLIER -73.02 162.2 29.77 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.245 -1.15 . . . . 2.78 108.191 179.307 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 1.077 ' HB2' HG13 ' A' ' 4' ' ' VAL . 23.2 m-85 -147.49 164.56 33.0 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-O 122.45 1.119 . . . . 2.48 111.437 -179.184 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.861 ' O ' HG22 ' A' ' 84' ' ' VAL . 21.2 p -147.64 119.37 8.06 Favored 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 106.299 -1.741 . . . . 3.45 106.299 178.26 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.6 ' CG1' ' HB2' ' A' ' 81' ' ' LEU . 10.0 t -52.55 169.18 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.286 -2.175 0 C-N-CA 118.495 -1.282 . . . . 2.54 108.708 -178.498 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.536 ' H ' HG12 ' A' ' 63' ' ' VAL . 2.1 t-80 -132.32 127.36 35.4 Favored 'General case' 0 C--N 1.293 -1.876 0 O-C-N 121.443 -0.785 . . . . 3.81 109.127 -179.213 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.656 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 0.6 OUTLIER -72.73 1.82 7.74 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.385 -0.822 . . . . 4.2 109.976 -179.961 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -57.2 -19.67 22.29 Favored 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 107.287 -1.375 . . . . 1.79 107.287 178.553 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.528 ' CB ' ' O ' ' A' ' 80' ' ' ARG . 48.5 m -95.67 -10.38 29.51 Favored 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.84 -0.537 . . . . 3.21 109.798 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.723 ' C ' HD11 ' B' ' 37' ' ' LEU . 2.8 m-30 -77.88 155.89 30.68 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.136 -0.977 . . . . 2.73 109.772 -178.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.48 ' HG2' ' O ' ' A' ' 68' ' ' PHE . 3.7 mtmt -150.45 165.01 34.47 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.369 -0.832 . . . . 2.61 109.334 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.906 HG21 HG21 ' B' ' 43' ' ' VAL . 1.7 t -97.91 117.59 42.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.312 -0.868 . . . . 2.02 109.133 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -79.16 172.2 55.15 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.585 -1.406 . . . . 2.53 109.585 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -77.04 1.02 19.15 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.096 -1.238 . . . . 6.73 109.893 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -89.49 1.75 55.48 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 121.544 -0.723 . . . . 2.9 109.347 179.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.747 ' C ' HG22 ' B' ' 45' ' ' VAL . . . 70.31 50.35 27.58 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.508 -1.437 . . . . 2.62 109.508 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.611 ' N ' HG22 ' B' ' 45' ' ' VAL . 40.5 m -161.52 127.81 3.81 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.113 -1.228 . . . . 2.78 109.547 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.58 HD11 HD12 ' B' ' 37' ' ' LEU . 0.3 OUTLIER -53.48 154.32 3.58 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.232 -0.918 . . . . 1.34 109.323 179.937 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . 0.531 ' CG ' ' O ' ' A' ' 76' ' ' LEU . 22.4 mtp -160.29 117.49 2.49 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.228 -0.92 . . . . 3.76 109.474 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.638 HG12 ' CE1' ' A' ' 68' ' ' PHE . 4.9 mt -59.01 134.35 24.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.29 -0.881 . . . . 1.52 109.565 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.45 ' CG ' ' HE2' ' A' ' 69' ' ' LYS . 26.5 t70 -103.22 -21.13 13.9 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.285 -1.005 . . . . 2.41 108.285 178.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.799 ' NH1' HG21 ' A' ' 48' ' ' THR . 0.0 OUTLIER 174.47 68.95 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 107.304 -1.369 . . . . 1.75 107.304 179.357 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.649 ' O ' HD23 ' A' ' 81' ' ' LEU . 0.9 OUTLIER -31.48 121.35 0.25 Allowed 'General case' 0 C--N 1.297 -1.693 0 CA-C-N 115.285 -0.87 . . . . 3.62 111.797 -178.151 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.49 ' O ' ' CB ' ' A' ' 64' ' ' HIS . 0.1 OUTLIER -90.7 104.24 16.85 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.004 -1.11 . . . . 8.07 108.004 178.678 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.934 ' HB2' HD11 ' A' ' 47' ' ' ILE . 0.5 OUTLIER -73.47 148.85 42.8 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.271 -0.893 . . . . 2.69 111.099 -178.474 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.861 HG22 ' O ' ' A' ' 62' ' ' THR . 25.0 m -148.79 156.12 41.2 Favored Pre-proline 0 C--N 1.302 -1.49 0 N-CA-C 107.872 -1.159 . . . . 2.86 107.872 179.498 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.575 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 24.1 Cg_endo -62.42 147.84 94.25 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 C-N-CA 122.022 1.814 . . . . 2.86 110.604 179.035 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.877 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . . . -87.13 130.39 34.54 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.179 -0.951 . . . . 3.64 109.421 -178.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.509 0 CA-C-O 118.0 -1.0 . . . . 8.95 109.531 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.597 ' SD ' HG21 ' B' ' 62' ' ' THR . 26.4 ttm . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 121.397 0.617 . . . . 6.92 109.38 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 2' ' ' ILE . . . . . 0.648 ' CA ' HD22 ' A' ' 65' ' ' LEU . 2.4 mt -76.98 80.83 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 N-CA-C 108.025 -1.102 . . . . 2.57 108.025 179.582 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . 0.831 ' O ' HG13 ' B' ' 35' ' ' VAL . 36.7 mttt -64.02 177.17 0.83 Allowed 'General case' 0 N--CA 1.493 1.698 0 CA-C-O 121.964 0.888 . . . . 2.83 111.674 -178.061 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 4' ' ' VAL . . . . . 1.076 HG13 ' HB2' ' B' ' 61' ' ' TYR . 2.0 p 172.27 149.74 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 N-CA-C 108.807 -0.812 . . . . 3.97 108.807 179.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 5' ' ' GLU . . . . . 0.545 ' O ' ' HB2' ' B' ' 34' ' ' TYR . 44.2 mt-10 -123.67 113.8 19.12 Favored 'General case' 0 C--N 1.292 -1.903 0 O-C-N 121.336 -0.853 . . . . 3.84 109.789 -179.736 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . 0.802 HD13 ' HB3' ' B' ' 56' ' ' TYR . 0.2 OUTLIER -73.64 101.32 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 N-CA-C 107.757 -1.201 . . . . 1.47 107.757 179.004 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 7' ' ' LYS . . . . . 0.672 ' HD3' ' CD2' ' B' ' 34' ' ' TYR . 0.0 OUTLIER -44.14 170.03 0.05 OUTLIER Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.386 -0.821 . . . . 2.41 110.013 -179.06 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 8' ' ' PRO . . . . . 0.46 ' HD2' ' HB3' ' B' ' 7' ' ' LYS . 33.2 Cg_endo -74.66 -25.06 12.97 Favored 'Trans proline' 0 C--N 1.311 -1.443 0 C-N-CA 122.415 2.077 . . . . 2.71 109.813 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -89.91 -0.27 57.47 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 108.93 -0.767 . . . . 3.45 108.93 178.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 10' ' ' GLN . . . . . 0.503 ' O ' ' NE2' ' B' ' 31' ' ' GLN . 6.2 mm-40 -118.38 38.25 3.78 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.325 -0.859 . . . . 4.63 109.25 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 11' ' ' ALA . . . . . 0.417 ' O ' ' HB3' ' B' ' 55' ' ' ALA . . . -103.3 10.35 37.6 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.124 -0.985 . . . . 1.81 110.333 -179.245 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 12' ' ' GLN . . . . . 0.426 ' HA ' ' CB ' ' B' ' 55' ' ' ALA . 34.5 mt-30 -136.67 135.71 38.46 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.044 -1.035 . . . . 5.66 110.036 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 13' ' ' PHE . . . . . 0.643 ' CD1' ' HB3' ' B' ' 29' ' ' ASN . 28.6 p90 -86.05 170.83 11.89 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.409 -0.807 . . . . 2.95 109.519 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 96.6 m -136.73 151.15 48.9 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.378 -0.826 . . . . 4.44 108.972 179.16 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.06 112.66 22.09 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.239 -0.913 . . . . 2.89 109.41 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -129.47 147.71 51.31 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.328 -0.858 . . . . 9.22 109.376 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -54.43 107.02 0.24 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.277 -0.89 . . . . 3.53 109.429 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 18' ' ' GLY . . . . . 0.582 ' HA3' ' CE1' ' B' ' 26' ' ' TYR . . . -104.89 165.29 14.46 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.418 -1.473 . . . . 6.14 109.418 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 19' ' ' VAL . . . . . 0.423 ' C ' ' CE2' ' B' ' 26' ' ' TYR . 0.9 OUTLIER -135.98 115.1 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.188 -1.184 . . . . 9.27 108.91 179.429 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 20' ' ' SER . . . . . 0.471 ' N ' ' CE2' ' B' ' 26' ' ' TYR . 0.5 OUTLIER -46.91 -78.85 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.394 -0.816 . . . . 11.3 109.552 -179.313 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 21' ' ' ARG . . . . . 0.465 ' O ' ' CB ' ' B' ' 22' ' ' GLN . 56.9 mtp180 -148.56 53.17 1.0 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.272 -0.892 . . . . 9.52 109.6 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 22' ' ' GLN . . . . . 0.465 ' CB ' ' O ' ' B' ' 21' ' ' ARG . 5.2 mt-30 73.38 20.98 3.09 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.176 -0.952 . . . . 13.35 109.323 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 23' ' ' GLY . . . . . 0.445 ' C ' ' CG ' ' B' ' 24' ' ' LYS . . . -106.22 -51.37 0.83 Allowed Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.534 -1.426 . . . . 7.9 109.534 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 24' ' ' LYS . . . . . 0.445 ' CG ' ' C ' ' B' ' 23' ' ' GLY . 1.1 mttt -154.86 149.78 20.38 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.203 -1.175 . . . . 5.46 109.541 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -78.28 115.77 3.77 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 122.727 2.284 . . . . 5.38 110.316 179.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 26' ' ' TYR . . . . . 0.603 ' CD1' ' O ' ' B' ' 26' ' ' TYR . 6.3 p90 -111.08 141.07 45.06 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.127 -0.983 . . . . 7.28 109.718 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 27' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -98.03 78.97 2.56 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.148 -0.97 . . . . 4.06 108.727 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . 0.599 ' HB2' ' CE1' ' B' ' 26' ' ' TYR . 0.2 OUTLIER -92.39 170.64 9.62 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.195 -0.94 . . . . 7.71 110.298 -179.197 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 29' ' ' ASN . . . . . 0.643 ' HB3' ' CD1' ' B' ' 13' ' ' PHE . 0.0 OUTLIER -92.92 121.92 34.76 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.623 -0.88 . . . . 4.9 108.623 179.559 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 30' ' ' GLU . . . . . 0.459 ' O ' ' HA ' ' B' ' 13' ' ' PHE . 2.8 mt-10 -109.94 156.05 20.95 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.097 -1.002 . . . . 3.29 109.77 -179.45 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 31' ' ' GLN . . . . . 0.627 ' HB2' HD23 ' B' ' 49' ' ' LEU . 0.0 OUTLIER -137.63 -169.26 2.49 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.25 -0.906 . . . . 3.28 109.829 179.948 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . 0.896 ' HB3' HD11 ' B' ' 44' ' ' LEU . 1.2 mt -134.74 173.86 11.21 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.429 -0.794 . . . . 2.59 109.34 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 33' ' ' CYS . . . . . 0.527 ' HB2' HG21 ' B' ' 4' ' ' VAL . 0.0 OUTLIER -168.36 165.94 12.6 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.058 -1.026 . . . . 1.83 108.274 -179.812 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 34' ' ' TYR . . . . . 0.934 ' C ' HG23 ' B' ' 4' ' ' VAL . 17.8 m-85 -119.66 96.66 5.28 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.053 -1.029 . . . . 3.34 109.438 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 35' ' ' VAL . . . . . 0.914 ' O ' HG22 ' B' ' 43' ' ' VAL . 2.9 t -95.37 113.65 30.24 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 O-C-N 121.196 -0.94 . . . . 1.52 110.658 -179.469 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 36' ' ' ASP . . . . . 0.437 ' O ' ' N ' ' B' ' 39' ' ' ASN . 1.4 m-20 -62.82 -35.53 80.2 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 106.989 -1.486 . . . . 3.99 106.989 178.174 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 37' ' ' LEU . . . . . 0.723 HD11 ' C ' ' A' ' 68' ' ' PHE . 3.3 tt 49.09 21.35 0.48 Allowed 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 121.614 0.721 . . . . 2.4 110.039 178.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 88.35 14.33 62.16 Favored Glycine 0 N--CA 1.482 1.701 0 N-CA-C 109.094 -1.602 . . . . 2.7 109.094 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 39' ' ' ASN . . . . . 0.636 HD22 HG11 ' B' ' 43' ' ' VAL . 42.2 m-20 -94.74 12.89 26.3 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.333 -1.098 . . . . 3.51 109.82 -179.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 40' ' ' GLU . . . . . 0.525 ' HB2' ' O ' ' B' ' 39' ' ' ASN . 19.5 mt-10 70.61 -52.36 0.66 Allowed 'General case' 0 N--CA 1.499 1.995 0 CA-C-O 121.663 0.744 . . . . 4.11 110.356 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 41' ' ' HIS . . . . . 0.481 ' HB3' ' HD2' ' B' ' 42' ' ' PRO . 18.3 m80 -97.59 161.58 25.38 Favored Pre-proline 0 C--N 1.291 -1.974 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 42' ' ' PRO . . . . . 0.661 ' HB2' ' CD1' ' B' ' 34' ' ' TYR . 37.0 Cg_endo -77.83 137.99 16.38 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 122.068 1.845 . . . . 3.44 110.287 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 43' ' ' VAL . . . . . 0.914 HG22 ' O ' ' B' ' 35' ' ' VAL . 3.9 m -110.66 115.17 49.11 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 O-C-N 121.221 -0.924 . . . . 3.58 109.207 179.421 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . 0.896 HD11 ' HB3' ' B' ' 32' ' ' LEU . 60.7 tp -68.03 101.26 1.1 Allowed 'General case' 0 C--N 1.302 -1.496 0 C-N-CA 119.331 -0.948 . . . . 2.65 109.056 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 45' ' ' VAL . . . . . 0.747 HG22 ' C ' ' A' ' 74' ' ' GLY . 0.3 OUTLIER -110.37 157.94 10.85 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 N-CA-C 109.121 -0.696 . . . . 2.66 109.121 -179.48 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 46' ' ' LYS . . . . . 0.461 ' HB2' ' O ' ' A' ' 74' ' ' GLY . 9.3 mtpt -81.52 172.63 13.25 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.087 -1.008 . . . . 3.89 110.177 -179.252 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 47' ' ' ILE . . . . . 0.945 HD13 HD12 ' B' ' 83' ' ' LEU . 0.5 OUTLIER -159.83 154.29 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 N-CA-C 108.728 -0.842 . . . . 4.07 108.728 179.814 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 48' ' ' THR . . . . . 0.801 HG21 ' NH1' ' B' ' 80' ' ' ARG . 0.2 OUTLIER -95.0 149.02 21.7 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.03 -1.044 . . . . 3.44 109.579 -179.998 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 49' ' ' LEU . . . . . 0.703 HD21 ' HA ' ' B' ' 55' ' ' ALA . 0.2 OUTLIER -119.1 113.13 20.44 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.802 -0.814 . . . . 4.57 108.802 179.932 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 50' ' ' ASP . . . . . 0.455 ' O ' ' ND2' ' B' ' 29' ' ' ASN . 0.1 OUTLIER -53.36 149.8 7.1 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.242 -0.911 . . . . 4.77 109.941 -179.455 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -63.12 117.44 6.51 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.355 -0.841 . . . . 6.49 109.404 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . 96.06 -18.32 57.66 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.456 -1.457 . . . . 4.11 109.456 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -75.22 144.3 78.35 Favored Pre-proline 0 N--CA 1.488 1.44 0 O-C-N 121.176 -1.19 . . . . 3.06 109.318 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 54' ' ' PRO . . . . . 0.424 ' O ' ' C ' ' B' ' 55' ' ' ALA . 35.5 Cg_endo -78.28 123.65 6.18 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.578 2.185 . . . . 3.16 110.566 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 55' ' ' ALA . . . . . 0.703 ' HA ' HD21 ' B' ' 49' ' ' LEU . . . -41.07 146.69 0.16 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.338 -0.851 . . . . 1.73 110.152 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 56' ' ' TYR . . . . . 0.802 ' HB3' HD13 ' B' ' 6' ' ' ILE . 87.7 m-85 -47.58 98.08 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.376 -0.827 . . . . 2.45 109.004 179.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 57' ' ' ALA . . . . . 0.864 ' HB1' ' HD2' ' B' ' 58' ' ' PRO . . . -46.2 171.75 0.06 OUTLIER Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.187 -0.945 . . . . 1.16 109.698 -179.513 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 58' ' ' PRO . . . . . 0.864 ' HD2' ' HB1' ' B' ' 57' ' ' ALA . 35.6 Cg_endo -77.92 111.68 3.14 Favored 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 122.675 2.25 . . . . 1.99 110.196 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 176.63 -178.28 47.94 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.756 -1.338 . . . . 0.9 109.756 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 60' ' ' LEU . . . . . 0.851 ' HB3' ' HB3' ' B' ' 86' ' ' ALA . 0.1 OUTLIER -73.17 162.12 29.79 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.202 -1.176 . . . . 2.78 107.993 179.106 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 61' ' ' TYR . . . . . 1.076 ' HB2' HG13 ' B' ' 4' ' ' VAL . 24.0 m-85 -147.49 164.46 33.31 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-O 122.43 1.109 . . . . 2.48 111.386 -179.182 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 62' ' ' THR . . . . . 0.865 ' O ' HG22 ' B' ' 84' ' ' VAL . 21.4 p -147.49 119.51 8.21 Favored 'General case' 0 C--N 1.292 -1.891 0 N-CA-C 106.236 -1.764 . . . . 3.45 106.236 178.214 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 63' ' ' VAL . . . . . 0.593 ' CG1' ' HB2' ' B' ' 81' ' ' LEU . 10.1 t -52.59 169.18 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.286 -2.17 0 C-N-CA 118.556 -1.258 . . . . 2.54 108.673 -178.517 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 64' ' ' HIS . . . . . 0.54 ' H ' HG12 ' B' ' 63' ' ' VAL . 2.1 t-80 -132.31 127.42 35.56 Favored 'General case' 0 C--N 1.293 -1.851 0 O-C-N 121.412 -0.805 . . . . 3.81 109.113 -179.211 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 65' ' ' LEU . . . . . 0.648 ' HB2' ' CD2' ' B' ' 68' ' ' PHE . 0.6 OUTLIER -72.78 1.9 7.68 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.398 -0.813 . . . . 4.19 109.976 -179.994 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -57.18 -19.71 22.21 Favored 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 107.247 -1.39 . . . . 1.79 107.247 178.525 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . 0.54 ' CB ' ' O ' ' B' ' 80' ' ' ARG . 47.8 m -95.74 -10.57 28.84 Favored 'General case' 0 N--CA 1.485 1.321 0 O-C-N 121.875 -0.516 . . . . 3.21 109.848 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 68' ' ' PHE . . . . . 0.713 ' C ' HD11 ' A' ' 37' ' ' LEU . 2.8 m-30 -77.65 155.72 31.2 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.128 -0.982 . . . . 2.73 109.664 -179.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 69' ' ' LYS . . . . . 0.472 ' HG2' ' O ' ' B' ' 68' ' ' PHE . 3.7 mtmt -150.27 164.98 34.36 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.361 -0.837 . . . . 2.61 109.337 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 70' ' ' VAL . . . . . 0.88 HG21 HG21 ' A' ' 43' ' ' VAL . 1.7 t -97.95 117.6 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.322 -0.861 . . . . 2.02 109.118 179.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . -79.11 172.21 55.18 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.604 -1.398 . . . . 2.53 109.604 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 72' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -77.1 1.02 19.36 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.141 -1.211 . . . . 6.74 109.858 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -89.53 1.82 55.42 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 121.57 -0.706 . . . . 2.9 109.294 179.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 74' ' ' GLY . . . . . 0.764 ' C ' HG22 ' A' ' 45' ' ' VAL . . . 70.23 50.31 28.28 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.552 -1.419 . . . . 2.62 109.552 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 75' ' ' SER . . . . . 0.62 ' N ' HG22 ' A' ' 45' ' ' VAL . 40.5 m -161.44 127.79 3.84 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.152 -1.205 . . . . 2.78 109.586 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 76' ' ' LEU . . . . . 0.585 HD11 HD12 ' A' ' 37' ' ' LEU . 0.3 OUTLIER -53.53 154.29 3.66 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.209 -0.932 . . . . 1.34 109.345 179.948 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 77' ' ' MET . . . . . 0.523 ' CG ' ' O ' ' B' ' 76' ' ' LEU . 22.4 mtp -160.27 117.6 2.51 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.243 -0.911 . . . . 3.76 109.47 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 78' ' ' ILE . . . . . 0.638 HG12 ' CE1' ' B' ' 68' ' ' PHE . 4.9 mt -59.17 134.39 24.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.33 -0.856 . . . . 1.52 109.617 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 79' ' ' ASP . . . . . 0.449 ' CG ' ' HE2' ' B' ' 69' ' ' LYS . 26.3 t70 -103.23 -21.04 13.91 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.239 -1.023 . . . . 2.4 108.239 178.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 80' ' ' ARG . . . . . 0.801 ' NH1' HG21 ' B' ' 48' ' ' THR . 0.0 OUTLIER 174.39 69.07 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 107.242 -1.392 . . . . 1.75 107.242 179.325 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 81' ' ' LEU . . . . . 0.654 HD23 ' O ' ' B' ' 81' ' ' LEU . 0.8 OUTLIER -31.55 121.31 0.26 Allowed 'General case' 0 C--N 1.297 -1.696 0 CA-C-N 115.235 -0.893 . . . . 3.62 111.818 -178.191 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 82' ' ' ARG . . . . . 0.494 ' O ' ' CB ' ' B' ' 64' ' ' HIS . 0.1 OUTLIER -90.69 104.31 16.91 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 107.962 -1.125 . . . . 8.07 107.962 178.701 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 83' ' ' LEU . . . . . 0.945 HD12 HD13 ' B' ' 47' ' ' ILE . 0.5 OUTLIER -73.51 148.85 42.71 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.252 -0.905 . . . . 2.69 111.099 -178.509 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 84' ' ' VAL . . . . . 0.865 HG22 ' O ' ' B' ' 62' ' ' THR . 24.9 m -148.73 156.22 41.39 Favored Pre-proline 0 C--N 1.302 -1.49 0 N-CA-C 107.853 -1.166 . . . . 2.86 107.853 179.546 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 85' ' ' PRO . . . . . 0.575 ' HA ' ' O ' ' B' ' 60' ' ' LEU . 24.3 Cg_endo -62.54 147.77 94.33 Favored 'Trans proline' 0 C--N 1.304 -1.782 0 C-N-CA 122.102 1.868 . . . . 2.86 110.612 178.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 86' ' ' ALA . . . . . 0.851 ' HB3' ' HB3' ' B' ' 60' ' ' LEU . . . -87.13 130.33 34.57 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.187 -0.945 . . . . 3.64 109.385 -178.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 117.945 -1.026 . . . . 8.95 109.488 179.854 . . . . . . . . 1 1 . 1 stop_ save_